| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G-rich strand telomeric DNA binding | 3.98e-06 | 11 | 59 | 3 | GO:0098505 | |
| GeneOntologyMolecularFunction | single-stranded telomeric DNA binding | 6.86e-06 | 13 | 59 | 3 | GO:0043047 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.02e-05 | 46 | 59 | 4 | GO:0030020 | |
| GeneOntologyMolecularFunction | sequence-specific single stranded DNA binding | 1.09e-05 | 15 | 59 | 3 | GO:0098847 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.91e-05 | 188 | 59 | 6 | GO:0005201 | |
| GeneOntologyMolecularFunction | denatured protein binding | 2.57e-05 | 3 | 59 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 5.13e-05 | 4 | 59 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | death receptor agonist activity | 8.53e-05 | 5 | 59 | 2 | GO:0038177 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.28e-04 | 6 | 59 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 1.28e-04 | 6 | 59 | 2 | GO:0140545 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 1.28e-04 | 6 | 59 | 2 | GO:0055131 | |
| GeneOntologyMolecularFunction | telomeric DNA binding | 2.24e-04 | 40 | 59 | 3 | GO:0042162 | |
| GeneOntologyMolecularFunction | mRNA CDS binding | 2.38e-04 | 8 | 59 | 2 | GO:1990715 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 3.25e-04 | 111 | 59 | 4 | GO:0003727 | |
| GeneOntologyMolecularFunction | transcription factor binding | 3.41e-04 | 753 | 59 | 9 | GO:0008134 | |
| GeneOntologyMolecularFunction | miRNA binding | 3.86e-04 | 48 | 59 | 3 | GO:0035198 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 4.69e-04 | 337 | 59 | 6 | GO:0031625 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 5.56e-04 | 12 | 59 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase binding | 6.45e-04 | 358 | 59 | 6 | GO:0044389 | |
| GeneOntologyMolecularFunction | pre-mRNA intronic binding | 7.63e-04 | 14 | 59 | 2 | GO:0097157 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 7.63e-04 | 14 | 59 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 7.81e-04 | 61 | 59 | 3 | GO:0030374 | |
| GeneOntologyMolecularFunction | regulatory RNA binding | 8.19e-04 | 62 | 59 | 3 | GO:0061980 | |
| GeneOntologyMolecularFunction | protein-containing complex destabilizing activity | 8.79e-04 | 15 | 59 | 2 | GO:0140776 | |
| GeneOntologyMolecularFunction | pre-mRNA binding | 8.98e-04 | 64 | 59 | 3 | GO:0036002 | |
| GeneOntologyMolecularFunction | histone deacetylase binding | 9.37e-04 | 147 | 59 | 4 | GO:0042826 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 1.27e-03 | 560 | 59 | 7 | GO:0001228 | |
| GeneOntologyMolecularFunction | misfolded protein binding | 1.27e-03 | 18 | 59 | 2 | GO:0051787 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.27e-03 | 18 | 59 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.29e-03 | 562 | 59 | 7 | GO:0003712 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | 1.32e-03 | 276 | 59 | 5 | GO:0003730 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 1.35e-03 | 566 | 59 | 7 | GO:0001216 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 1.58e-03 | 20 | 59 | 2 | GO:0061665 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 1.58e-03 | 582 | 59 | 7 | GO:0140297 | |
| GeneOntologyMolecularFunction | death receptor activity | 1.74e-03 | 21 | 59 | 2 | GO:0005035 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | PEF1 ZMIZ2 ACTN4 EWSR1 ZMIZ1 ARID1A HSPA1A HSPA1B HNRNPA2B1 AR | 1.96e-03 | 1160 | 59 | 10 | GO:0030674 |
| GeneOntologyMolecularFunction | protease binding | 2.02e-03 | 181 | 59 | 4 | GO:0002020 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 3.78e-03 | 31 | 59 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 4.03e-03 | 875 | 59 | 8 | GO:0019904 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 4.27e-03 | 33 | 59 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | structural molecule activity | 4.49e-03 | 891 | 59 | 8 | GO:0005198 | |
| GeneOntologyMolecularFunction | NF-kappaB binding | 5.07e-03 | 36 | 59 | 2 | GO:0051059 | |
| GeneOntologyMolecularFunction | transcription regulator inhibitor activity | 5.07e-03 | 36 | 59 | 2 | GO:0140416 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 5.07e-03 | 36 | 59 | 2 | GO:0019789 | |
| GeneOntologyMolecularFunction | chromatin binding | 5.93e-03 | 739 | 59 | 7 | GO:0003682 | |
| GeneOntologyMolecularFunction | disordered domain specific binding | 5.93e-03 | 39 | 59 | 2 | GO:0097718 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | PEF1 ZMIZ2 ACTN4 EWSR1 ZMIZ1 ARID1A HSPA1A HSPA1B HNRNPA2B1 AR | 5.99e-03 | 1356 | 59 | 10 | GO:0060090 |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 6.23e-03 | 40 | 59 | 2 | GO:0140662 | |
| GeneOntologyMolecularFunction | calcium ion binding | 6.37e-03 | 749 | 59 | 7 | GO:0005509 | |
| GeneOntologyMolecularFunction | molecular condensate scaffold activity | 6.85e-03 | 42 | 59 | 2 | GO:0140693 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 7.30e-03 | 134 | 59 | 3 | GO:0003697 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 7.71e-03 | 417 | 59 | 5 | GO:0061629 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 9.85e-03 | 1459 | 59 | 10 | GO:0000977 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 1.03e-02 | 1244 | 59 | 9 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 1.18e-02 | 1271 | 59 | 9 | GO:0000987 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.23e-02 | 303 | 59 | 4 | GO:0003713 | |
| GeneOntologyMolecularFunction | protein kinase A binding | 1.28e-02 | 58 | 59 | 2 | GO:0051018 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 1.81e-06 | 207 | 58 | 7 | GO:0043484 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | SFPQ PABPN1 BAG4 HNRNPA3 PUM1 HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH3 HNRNPL | 7.47e-06 | 917 | 58 | 12 | GO:0016071 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | COL6A1 BMP7 FBN2 HOXD4 TREH DLX2 ELN ZMIZ1 CTNND1 PBX2 ARID1A AR RYR1 RYR2 | 8.16e-06 | 1269 | 58 | 14 | GO:0009887 |
| GeneOntologyBiologicalProcess | RNA splicing | SFPQ HNRNPA3 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.03e-05 | 502 | 58 | 9 | GO:0008380 |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 2.03e-05 | 416 | 58 | 8 | GO:0030522 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 6.29e-05 | 358 | 58 | 7 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 6.29e-05 | 358 | 58 | 7 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 6.74e-05 | 362 | 58 | 7 | GO:0000375 | |
| GeneOntologyBiologicalProcess | response to calcium ion | 8.93e-05 | 161 | 58 | 5 | GO:0051592 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | HOXA10 JUNB BMP7 SFPQ HOXD4 ZMIZ2 RFX6 ACTN4 DLX2 ZMIZ1 PBX2 FOXA3 AR | 1.01e-04 | 1390 | 58 | 13 | GO:0045944 |
| GeneOntologyBiologicalProcess | telomere maintenance | 1.09e-04 | 168 | 58 | 5 | GO:0000723 | |
| GeneOntologyBiologicalProcess | cellular heat acclimation | 1.16e-04 | 6 | 58 | 2 | GO:0070370 | |
| GeneOntologyBiologicalProcess | regulation of prostatic bud formation | 1.16e-04 | 6 | 58 | 2 | GO:0060685 | |
| GeneOntologyBiologicalProcess | embryo development | HOXA10 JUNB BMP7 PEF1 FBN2 HOXD4 DLG3 DLX2 ZMIZ1 PBX2 ARID1A AR RYR2 | 1.42e-04 | 1437 | 58 | 13 | GO:0009790 |
| GeneOntologyBiologicalProcess | mRNA processing | SFPQ PABPN1 HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH3 HNRNPL | 1.46e-04 | 551 | 58 | 8 | GO:0006397 |
| GeneOntologyBiologicalProcess | proximal/distal pattern formation | 1.53e-04 | 37 | 58 | 3 | GO:0009954 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 1.53e-04 | 37 | 58 | 3 | GO:0014808 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 1.57e-04 | 713 | 58 | 9 | GO:0048598 | |
| GeneOntologyBiologicalProcess | heat acclimation | 1.62e-04 | 7 | 58 | 2 | GO:0010286 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 1.62e-04 | 7 | 58 | 2 | GO:0070434 | |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 1.71e-04 | 185 | 58 | 5 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 1.71e-04 | 185 | 58 | 5 | GO:0035108 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 1.79e-04 | 39 | 58 | 3 | GO:1903514 | |
| GeneOntologyBiologicalProcess | positive regulation of microtubule nucleation | 2.15e-04 | 8 | 58 | 2 | GO:0090063 | |
| GeneOntologyBiologicalProcess | positive regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 2.15e-04 | 8 | 58 | 2 | GO:0070426 | |
| GeneOntologyBiologicalProcess | telomere organization | 2.41e-04 | 199 | 58 | 5 | GO:0032200 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 2.57e-04 | 44 | 58 | 3 | GO:0070296 | |
| GeneOntologyBiologicalProcess | single fertilization | 3.02e-04 | 209 | 58 | 5 | GO:0007338 | |
| GeneOntologyBiologicalProcess | prostatic bud formation | 3.45e-04 | 10 | 58 | 2 | GO:0060513 | |
| GeneOntologyBiologicalProcess | androgen receptor signaling pathway | 3.99e-04 | 51 | 58 | 3 | GO:0030521 | |
| GeneOntologyBiologicalProcess | limb development | 4.14e-04 | 224 | 58 | 5 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 4.14e-04 | 224 | 58 | 5 | GO:0048736 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 4.21e-04 | 11 | 58 | 2 | GO:0070432 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 4.21e-04 | 11 | 58 | 2 | GO:0071313 | |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic pattern recognition receptor signaling pathway | 4.77e-04 | 129 | 58 | 4 | GO:0039531 | |
| GeneOntologyBiologicalProcess | negative regulation of inclusion body assembly | 5.04e-04 | 12 | 58 | 2 | GO:0090084 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 5.57e-04 | 239 | 58 | 5 | GO:0071383 | |
| GeneOntologyBiologicalProcess | response to hormone | HOXA10 COL6A1 BMP7 ANKRD26 ACTN4 ZMIZ1 ARID1A HSPA1A HSPA1B AR | 5.92e-04 | 1042 | 58 | 10 | GO:0009725 |
| GeneOntologyBiologicalProcess | lateral sprouting from an epithelium | 5.94e-04 | 13 | 58 | 2 | GO:0060601 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | 6.19e-04 | 1048 | 58 | 10 | GO:0014070 | |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor-mediated signaling pathway | 6.92e-04 | 14 | 58 | 2 | GO:1903265 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 6.92e-04 | 14 | 58 | 2 | GO:0071415 | |
| GeneOntologyBiologicalProcess | prostate gland development | 7.09e-04 | 62 | 58 | 3 | GO:0030850 | |
| GeneOntologyBiologicalProcess | mRNA transport | 7.40e-04 | 145 | 58 | 4 | GO:0051028 | |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 7.99e-04 | 148 | 58 | 4 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 7.99e-04 | 148 | 58 | 4 | GO:0035113 | |
| GeneOntologyBiologicalProcess | fertilization | 8.57e-04 | 263 | 58 | 5 | GO:0009566 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 9.09e-04 | 16 | 58 | 2 | GO:0070424 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | 9.25e-04 | 727 | 58 | 8 | GO:0032870 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 9.59e-04 | 561 | 58 | 7 | GO:0048568 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 1.02e-03 | 158 | 58 | 4 | GO:0050684 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 1.06e-03 | 276 | 58 | 5 | GO:0007179 | |
| GeneOntologyBiologicalProcess | response to metal ion | 1.07e-03 | 415 | 58 | 6 | GO:0010038 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial bud | 1.16e-03 | 18 | 58 | 2 | GO:0060572 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | 1.19e-03 | 1141 | 58 | 10 | GO:0045597 | |
| GeneOntologyBiologicalProcess | heart development | 1.20e-03 | 757 | 58 | 8 | GO:0007507 | |
| GeneOntologyBiologicalProcess | positive regulation of sequestering of calcium ion | 1.29e-03 | 19 | 58 | 2 | GO:0051284 | |
| GeneOntologyBiologicalProcess | regulation of microtubule nucleation | 1.29e-03 | 19 | 58 | 2 | GO:0010968 | |
| GeneOntologyBiologicalProcess | glomerulus development | 1.33e-03 | 77 | 58 | 3 | GO:0032835 | |
| GeneOntologyBiologicalProcess | muscle organ development | 1.38e-03 | 436 | 58 | 6 | GO:0007517 | |
| GeneOntologyBiologicalProcess | nucleotide-binding oligomerization domain containing 2 signaling pathway | 1.43e-03 | 20 | 58 | 2 | GO:0070431 | |
| GeneOntologyBiologicalProcess | positive regulation of pattern recognition receptor signaling pathway | 1.43e-03 | 79 | 58 | 3 | GO:0062208 | |
| GeneOntologyBiologicalProcess | urogenital system development | 1.43e-03 | 79 | 58 | 3 | GO:0001655 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 1.43e-03 | 79 | 58 | 3 | GO:0000380 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 1.48e-03 | 605 | 58 | 7 | GO:0071407 | |
| GeneOntologyBiologicalProcess | RNA transport | 1.49e-03 | 175 | 58 | 4 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 1.49e-03 | 175 | 58 | 4 | GO:0050657 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 1.49e-03 | 443 | 58 | 6 | GO:1903311 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 1.53e-03 | 445 | 58 | 6 | GO:0141091 | |
| GeneOntologyBiologicalProcess | regulation of inclusion body assembly | 1.58e-03 | 21 | 58 | 2 | GO:0090083 | |
| GeneOntologyBiologicalProcess | response to caffeine | 1.58e-03 | 21 | 58 | 2 | GO:0031000 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 1.58e-03 | 178 | 58 | 4 | GO:0051236 | |
| GeneOntologyBiologicalProcess | regulation of DNA-binding transcription factor activity | 1.60e-03 | 449 | 58 | 6 | GO:0051090 | |
| GeneOntologyBiologicalProcess | skeletal system development | 1.63e-03 | 615 | 58 | 7 | GO:0001501 | |
| GeneOntologyCellularComponent | chromatin | FOXS1 HOXA10 JUNB SFPQ HOXD4 ZMIZ2 RFX6 DLX2 ZMIZ1 PBX2 ARID1A FOXA3 RPA2 HNRNPA2B1 AR HNRNPL | 2.19e-06 | 1480 | 59 | 16 | GO:0000785 |
| GeneOntologyCellularComponent | collagen type VI trimer | 2.35e-05 | 3 | 59 | 2 | GO:0005589 | |
| GeneOntologyCellularComponent | collagen beaded filament | 2.35e-05 | 3 | 59 | 2 | GO:0098647 | |
| GeneOntologyCellularComponent | postsynaptic density | 3.73e-05 | 451 | 59 | 8 | GO:0014069 | |
| GeneOntologyCellularComponent | asymmetric synapse | 5.54e-05 | 477 | 59 | 8 | GO:0032279 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 8.02e-05 | 503 | 59 | 8 | GO:0099572 | |
| GeneOntologyCellularComponent | extracellular matrix | 8.64e-05 | 656 | 59 | 9 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 8.84e-05 | 658 | 59 | 9 | GO:0030312 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.05e-04 | 523 | 59 | 8 | GO:0098984 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 1.12e-04 | 88 | 59 | 4 | GO:0016529 | |
| GeneOntologyCellularComponent | collagen trimer | 1.12e-04 | 88 | 59 | 4 | GO:0005581 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.15e-04 | 530 | 59 | 8 | GO:0062023 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 1.63e-04 | 97 | 59 | 4 | GO:0071013 | |
| GeneOntologyCellularComponent | sarcolemma | 1.98e-04 | 190 | 59 | 5 | GO:0042383 | |
| GeneOntologyCellularComponent | chromaffin granule membrane | 2.78e-04 | 9 | 59 | 2 | GO:0042584 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 2.79e-04 | 45 | 59 | 3 | GO:0033017 | |
| GeneOntologyCellularComponent | sarcoplasm | 3.03e-04 | 114 | 59 | 4 | GO:0016528 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 3.47e-04 | 10 | 59 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | spliceosomal complex | 3.50e-04 | 215 | 59 | 5 | GO:0005681 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | JUNB SFPQ PYGO2 HNRNPA3 ARID1A RPA2 HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH3 | 3.94e-04 | 1377 | 59 | 12 | GO:0140513 |
| GeneOntologyCellularComponent | ribonucleoprotein complex | PABPN1 HNRNPA3 ACTN4 HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 4.49e-04 | 1194 | 59 | 11 | GO:1990904 |
| GeneOntologyCellularComponent | postsynapse | PRR12 SRI HNRNPA3 SYP DLG3 ACTN4 CTNND1 HNRNPA2B1 HNRNPH1 HNRNPH2 | 5.12e-04 | 1018 | 59 | 10 | GO:0098794 |
| GeneOntologyCellularComponent | chromaffin granule | 8.03e-04 | 15 | 59 | 2 | GO:0042583 | |
| GeneOntologyCellularComponent | Z disc | 8.75e-04 | 151 | 59 | 4 | GO:0030018 | |
| GeneOntologyCellularComponent | myofibril | 1.03e-03 | 273 | 59 | 5 | GO:0030016 | |
| GeneOntologyCellularComponent | I band | 1.24e-03 | 166 | 59 | 4 | GO:0031674 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.35e-03 | 290 | 59 | 5 | GO:0043292 | |
| GeneOntologyCellularComponent | inclusion body | 2.11e-03 | 90 | 59 | 3 | GO:0016234 | |
| GeneOntologyCellularComponent | nuclear body | 3.70e-03 | 903 | 59 | 8 | GO:0016604 | |
| GeneOntologyCellularComponent | COP9 signalosome | 5.16e-03 | 38 | 59 | 2 | GO:0008180 | |
| GeneOntologyCellularComponent | sarcomere | 5.36e-03 | 249 | 59 | 4 | GO:0030017 | |
| GeneOntologyCellularComponent | supramolecular fiber | 5.51e-03 | 1179 | 59 | 9 | GO:0099512 | |
| GeneOntologyCellularComponent | aggresome | 5.70e-03 | 40 | 59 | 2 | GO:0016235 | |
| GeneOntologyCellularComponent | supramolecular polymer | 5.76e-03 | 1187 | 59 | 9 | GO:0099081 | |
| GeneOntologyCellularComponent | bicellular tight junction | 6.05e-03 | 131 | 59 | 3 | GO:0005923 | |
| GeneOntologyCellularComponent | nuclear replication fork | 6.27e-03 | 42 | 59 | 2 | GO:0043596 | |
| GeneOntologyCellularComponent | extrinsic component of plasma membrane | 6.85e-03 | 137 | 59 | 3 | GO:0019897 | |
| GeneOntologyCellularComponent | tight junction | 7.13e-03 | 139 | 59 | 3 | GO:0070160 | |
| GeneOntologyCellularComponent | nuclear speck | 7.32e-03 | 431 | 59 | 5 | GO:0016607 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 7.48e-03 | 46 | 59 | 2 | GO:0005790 | |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 8.46e-03 | 49 | 59 | 2 | GO:0099092 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 8.76e-03 | 287 | 59 | 4 | GO:0035770 | |
| HumanPheno | Rimmed vacuoles | 2.74e-06 | 46 | 26 | 5 | HP:0003805 | |
| HumanPheno | Axial muscle weakness | 4.18e-06 | 50 | 26 | 5 | HP:0003327 | |
| HumanPheno | Abnormal axial muscle morphology | 5.10e-06 | 52 | 26 | 5 | HP:0040286 | |
| HumanPheno | Dysphonia | 1.01e-05 | 159 | 26 | 7 | HP:0001618 | |
| HumanPheno | Fatty replacement of skeletal muscle | 3.89e-05 | 39 | 26 | 4 | HP:0012548 | |
| HumanPheno | Generalized amyotrophy | 6.07e-05 | 86 | 26 | 5 | HP:0003700 | |
| HumanPheno | Abnormal knee physiology | 6.42e-05 | 87 | 26 | 5 | HP:0034670 | |
| HumanPheno | Ubiquitin-positive cerebral inclusion bodies | 7.49e-05 | 3 | 26 | 2 | HP:0012083 | |
| HumanPheno | Hyperlordosis | 8.79e-05 | 222 | 26 | 7 | HP:0003307 | |
| HumanPheno | Lordosis | 8.79e-05 | 222 | 26 | 7 | HP:0002939 | |
| HumanPheno | Elevated circulating creatine kinase concentration | 9.32e-05 | 306 | 26 | 8 | HP:0003236 | |
| HumanPheno | Slender finger | 1.15e-04 | 159 | 26 | 6 | HP:0001238 | |
| HumanPheno | Abnormal ankle morphology | 1.25e-04 | 100 | 26 | 5 | HP:0034673 | |
| HumanPheno | Abnormal circulating creatine kinase concentration | 1.34e-04 | 322 | 26 | 8 | HP:0040081 | |
| HumanPheno | Reduced muscle collagen VI | 1.49e-04 | 4 | 26 | 2 | HP:0030095 | |
| HumanPheno | Curved toe phalanx | 1.49e-04 | 4 | 26 | 2 | HP:0010176 | |
| HumanPheno | Reduced maximal expiratory pressure | 1.49e-04 | 4 | 26 | 2 | HP:0012497 | |
| HumanPheno | Abnormal circulating enzyme concentration | 1.52e-04 | 328 | 26 | 8 | HP:0011021 | |
| HumanPheno | Long toe | 1.56e-04 | 168 | 26 | 6 | HP:0010511 | |
| HumanPheno | Low hanging columella | 1.64e-04 | 56 | 26 | 4 | HP:0009765 | |
| HumanPheno | Ankle contracture | 2.14e-04 | 60 | 26 | 4 | HP:0034677 | |
| HumanPheno | Centrally nucleated skeletal muscle fibers | 2.14e-04 | 60 | 26 | 4 | HP:0003687 | |
| HumanPheno | Joint hypermobility | COL6A1 COL6A3 ELN ZMIZ1 ARID1A PUM1 MEFV HNRNPH1 HNRNPH2 RYR1 | 2.35e-04 | 557 | 26 | 10 | HP:0001382 |
| HumanPheno | Increased laxity of fingers | 2.48e-04 | 5 | 26 | 2 | HP:0006149 | |
| HumanPheno | Weakness of muscles of respiration | 2.52e-04 | 116 | 26 | 5 | HP:0004347 | |
| HumanPheno | Increased variability in muscle fiber diameter | 2.52e-04 | 116 | 26 | 5 | HP:0003557 | |
| HumanPheno | Abnormality of skeletal muscle fiber size | 3.07e-04 | 121 | 26 | 5 | HP:0012084 | |
| HumanPheno | Abnormality of the ankle | 3.25e-04 | 192 | 26 | 6 | HP:0003028 | |
| HumanPheno | EMG: myopathic abnormalities | 4.13e-04 | 129 | 26 | 5 | HP:0003458 | |
| HumanPheno | Waddling gait | 4.28e-04 | 130 | 26 | 5 | HP:0002515 | |
| HumanPheno | Wrist hypermobility | 5.18e-04 | 7 | 26 | 2 | HP:0005072 | |
| HumanPheno | Increased endomysial connective tissue | 5.31e-04 | 32 | 26 | 3 | HP:0100297 | |
| HumanPheno | Abnormality of the musculature of the lower limbs | 5.36e-04 | 297 | 26 | 7 | HP:0001437 | |
| HumanPheno | Long fingers | 6.42e-04 | 306 | 26 | 7 | HP:0100807 | |
| HumanPheno | Muscular dystrophy | 6.48e-04 | 80 | 26 | 4 | HP:0003560 | |
| HumanPheno | Atrophic scars | 8.18e-04 | 37 | 26 | 3 | HP:0001075 | |
| HumanPheno | Distal joint hypermobility | 8.82e-04 | 9 | 26 | 2 | HP:0020152 | |
| HumanPheno | Wrist flexion contracture | 8.85e-04 | 38 | 26 | 3 | HP:0001239 | |
| MousePheno | centrally nucleated skeletal muscle fibers | 3.78e-07 | 80 | 50 | 6 | MP:0009404 | |
| MousePheno | decreased skeletal muscle size | 4.07e-07 | 81 | 50 | 6 | MP:0010240 | |
| MousePheno | abnormal skeletal muscle mass | 9.24e-07 | 149 | 50 | 7 | MP:0004817 | |
| MousePheno | abnormal skeletal muscle size | 9.25e-07 | 93 | 50 | 6 | MP:0009458 | |
| MousePheno | abnormal muscle morphology | COL6A1 COL6A3 FBN2 PABPN1 ACTN4 DLX2 EWSR1 ELN MARVELD2 ARID1A HNRNPA1 AR RYR1 RYR2 PPTC7 | 4.34e-06 | 1106 | 50 | 15 | MP:0002108 |
| MousePheno | decreased skeletal muscle mass | 6.84e-06 | 131 | 50 | 6 | MP:0004819 | |
| MousePheno | abnormal skeletal muscle fiber size | 1.00e-05 | 140 | 50 | 6 | MP:0009398 | |
| MousePheno | abnormal muscle fiber morphology | 1.17e-05 | 406 | 50 | 9 | MP:0004087 | |
| MousePheno | increased variability of skeletal muscle fiber size | 1.61e-05 | 43 | 50 | 4 | MP:0009403 | |
| MousePheno | myopathy | 4.01e-05 | 54 | 50 | 4 | MP:0000751 | |
| MousePheno | abnormal skeletal muscle morphology | 6.83e-05 | 508 | 50 | 9 | MP:0000759 | |
| MousePheno | decreased birth weight | 6.94e-05 | 121 | 50 | 5 | MP:0009674 | |
| MousePheno | abnormal sarcoplasmic reticulum morphology | 7.25e-05 | 23 | 50 | 3 | MP:0004088 | |
| MousePheno | abnormal birth weight | 7.50e-05 | 123 | 50 | 5 | MP:0009672 | |
| MousePheno | abnormal skeletal muscle fiber morphology | 1.03e-04 | 212 | 50 | 6 | MP:0003084 | |
| MousePheno | absent scrotum | 1.25e-04 | 5 | 50 | 2 | MP:0002670 | |
| MousePheno | abnormal muscle electrophysiology | 1.99e-04 | 32 | 50 | 3 | MP:0004145 | |
| MousePheno | abnormal muscle fiber mitochondrial morphology | 2.18e-04 | 33 | 50 | 3 | MP:0014342 | |
| MousePheno | small pterygoid bone | 2.60e-04 | 7 | 50 | 2 | MP:0004456 | |
| MousePheno | small prostate gland anterior lobe | 2.60e-04 | 7 | 50 | 2 | MP:0000664 | |
| MousePheno | short perineum | 3.46e-04 | 8 | 50 | 2 | MP:0003550 | |
| MousePheno | decreased skeletal muscle fiber size | 3.93e-04 | 97 | 50 | 4 | MP:0009400 | |
| MousePheno | muscle weakness | 4.09e-04 | 98 | 50 | 4 | MP:0000747 | |
| MousePheno | abnormal scrotum morphology | 4.44e-04 | 9 | 50 | 2 | MP:0002669 | |
| MousePheno | decreased skeletal muscle fiber diameter | 4.48e-04 | 42 | 50 | 3 | MP:0009402 | |
| MousePheno | impaired skeletal muscle contractility | 5.14e-04 | 44 | 50 | 3 | MP:0002841 | |
| MousePheno | abnormal intracellular organelle morphology | 6.49e-04 | 546 | 50 | 8 | MP:0014239 | |
| MousePheno | abnormal pterygoid bone morphology | 8.09e-04 | 12 | 50 | 2 | MP:0004453 | |
| Domain | RRM_1 | SFPQ PABPN1 HNRNPA3 EWSR1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 7.74e-10 | 208 | 58 | 10 | PF00076 |
| Domain | RRM | SFPQ PABPN1 HNRNPA3 EWSR1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.17e-09 | 217 | 58 | 10 | SM00360 |
| Domain | RRM_dom | SFPQ PABPN1 HNRNPA3 EWSR1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.81e-09 | 227 | 58 | 10 | IPR000504 |
| Domain | RRM | SFPQ PABPN1 HNRNPA3 EWSR1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 2.05e-09 | 230 | 58 | 10 | PS50102 |
| Domain | - | SFPQ PABPN1 HNRNPA3 EWSR1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 3.63e-09 | 244 | 58 | 10 | 3.30.70.330 |
| Domain | Nucleotide-bd_a/b_plait | SFPQ PABPN1 HNRNPA3 EWSR1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 6.19e-09 | 258 | 58 | 10 | IPR012677 |
| Domain | HnRNPA1 | 2.84e-05 | 3 | 58 | 2 | PF11627 | |
| Domain | Ryanrecept_TM4-6 | 2.84e-05 | 3 | 58 | 2 | IPR009460 | |
| Domain | zf-RNPHF | 2.84e-05 | 3 | 58 | 2 | PF08080 | |
| Domain | Znf_CHHC | 2.84e-05 | 3 | 58 | 2 | IPR012996 | |
| Domain | HnRNPA1 | 2.84e-05 | 3 | 58 | 2 | IPR021662 | |
| Domain | RyR | 2.84e-05 | 3 | 58 | 2 | PF02026 | |
| Domain | Ryanodine_rcpt | 2.84e-05 | 3 | 58 | 2 | IPR003032 | |
| Domain | RR_TM4-6 | 2.84e-05 | 3 | 58 | 2 | PF06459 | |
| Domain | Ryan_recept | 2.84e-05 | 3 | 58 | 2 | IPR013333 | |
| Domain | Collagen | 1.41e-04 | 85 | 58 | 4 | IPR008160 | |
| Domain | Collagen | 1.41e-04 | 85 | 58 | 4 | PF01391 | |
| Domain | RIH_assoc | 1.41e-04 | 6 | 58 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 1.41e-04 | 6 | 58 | 2 | IPR013662 | |
| Domain | RIH_dom | 1.41e-04 | 6 | 58 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.41e-04 | 6 | 58 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.41e-04 | 6 | 58 | 2 | IPR015925 | |
| Domain | - | 1.41e-04 | 6 | 58 | 2 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 1.41e-04 | 6 | 58 | 2 | PF01365 | |
| Domain | Ins145_P3_rec | 1.41e-04 | 6 | 58 | 2 | PF08709 | |
| Domain | EF-hand_8 | 1.59e-04 | 34 | 58 | 3 | PF13833 | |
| Domain | zf-MIZ | 1.97e-04 | 7 | 58 | 2 | PF02891 | |
| Domain | ZF_SP_RING | 1.97e-04 | 7 | 58 | 2 | PS51044 | |
| Domain | Znf_MIZ | 2.62e-04 | 8 | 58 | 2 | IPR004181 | |
| Domain | MIR | 4.20e-04 | 10 | 58 | 2 | PS50919 | |
| Domain | MIR | 4.20e-04 | 10 | 58 | 2 | PF02815 | |
| Domain | MIR | 4.20e-04 | 10 | 58 | 2 | SM00472 | |
| Domain | MIR_motif | 4.20e-04 | 10 | 58 | 2 | IPR016093 | |
| Domain | ConA-like_dom | 5.85e-04 | 219 | 58 | 5 | IPR013320 | |
| Domain | VWA | 7.01e-04 | 56 | 58 | 3 | PF00092 | |
| Domain | EF-hand_6 | 7.23e-04 | 13 | 58 | 2 | PF13405 | |
| Domain | EF_hand_dom | 7.60e-04 | 232 | 58 | 5 | IPR002048 | |
| Domain | HSP70 | 1.11e-03 | 16 | 58 | 2 | PF00012 | |
| Domain | HSP70_2 | 1.25e-03 | 17 | 58 | 2 | PS00329 | |
| Domain | HSP70_3 | 1.25e-03 | 17 | 58 | 2 | PS01036 | |
| Domain | HSP70_1 | 1.25e-03 | 17 | 58 | 2 | PS00297 | |
| Domain | EF-hand_1 | 1.27e-03 | 152 | 58 | 4 | PF00036 | |
| Domain | - | 1.28e-03 | 261 | 58 | 5 | 1.10.238.10 | |
| Domain | Hsp_70_fam | 1.40e-03 | 18 | 58 | 2 | IPR013126 | |
| Domain | EFh | 1.47e-03 | 158 | 58 | 4 | SM00054 | |
| Domain | - | 1.58e-03 | 74 | 58 | 3 | 3.40.50.410 | |
| Domain | EF-hand-dom_pair | 1.95e-03 | 287 | 58 | 5 | IPR011992 | |
| Domain | VWFA | 2.12e-03 | 82 | 58 | 3 | PS50234 | |
| Domain | VWA | 2.27e-03 | 84 | 58 | 3 | SM00327 | |
| Domain | SPRY | 2.50e-03 | 87 | 58 | 3 | SM00449 | |
| Domain | Homeobox_CS | 2.66e-03 | 186 | 58 | 4 | IPR017970 | |
| Domain | Homeobox_metazoa | 2.76e-03 | 90 | 58 | 3 | IPR020479 | |
| Domain | SPRY | 3.12e-03 | 94 | 58 | 3 | PF00622 | |
| Domain | SPRY_dom | 3.12e-03 | 94 | 58 | 3 | IPR003877 | |
| Domain | MARVEL | 3.16e-03 | 27 | 58 | 2 | PF01284 | |
| Domain | B30.2/SPRY | 3.21e-03 | 95 | 58 | 3 | IPR001870 | |
| Domain | B302_SPRY | 3.21e-03 | 95 | 58 | 3 | PS50188 | |
| Domain | Marvel | 3.40e-03 | 28 | 58 | 2 | IPR008253 | |
| Domain | MARVEL | 3.40e-03 | 28 | 58 | 2 | PS51225 | |
| Domain | VWF_A | 3.61e-03 | 99 | 58 | 3 | IPR002035 | |
| Domain | HMGI/Y_DNA-bd_CS | 4.16e-03 | 31 | 58 | 2 | IPR000637 | |
| Domain | - | 4.68e-03 | 218 | 58 | 4 | 1.10.10.10 | |
| Domain | EF_HAND_2 | 5.74e-03 | 231 | 58 | 4 | PS50222 | |
| Domain | Homeobox | 6.00e-03 | 234 | 58 | 4 | PF00046 | |
| Domain | HOMEOBOX_1 | 6.18e-03 | 236 | 58 | 4 | PS00027 | |
| Domain | HOX | 6.28e-03 | 237 | 58 | 4 | SM00389 | |
| Domain | HOMEOBOX_2 | 6.46e-03 | 239 | 58 | 4 | PS50071 | |
| Pathway | WP_MRNA_PROCESSING | 1.32e-07 | 126 | 45 | 7 | M39406 | |
| Pathway | WP_MRNA_PROCESSING | SFPQ PABPN1 HNRNPA3 EWSR1 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPL | 1.19e-06 | 451 | 45 | 10 | MM15946 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.12e-05 | 44 | 45 | 4 | M27812 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 2.51e-05 | 277 | 45 | 7 | MM15414 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 2.88e-05 | 283 | 45 | 7 | M13087 | |
| Pathway | REACTOME_MRNA_SPLICING | 4.00e-05 | 201 | 45 | 6 | MM15411 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 4.18e-05 | 300 | 45 | 7 | M610 | |
| Pathway | REACTOME_MRNA_SPLICING | 5.38e-05 | 212 | 45 | 6 | M14033 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 6.00e-05 | 67 | 45 | 4 | M26999 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 7.98e-05 | 140 | 45 | 5 | M587 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 8.40e-05 | 73 | 45 | 4 | MM14948 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | PABPN1 HNRNPA3 HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPL | 1.13e-04 | 612 | 45 | 9 | MM15547 |
| Pathway | REACTOME_HSF1_ACTIVATION | 1.28e-04 | 31 | 45 | 3 | M27252 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.32e-04 | 82 | 45 | 4 | M27250 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.41e-04 | 32 | 45 | 3 | MM14854 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.59e-04 | 258 | 45 | 6 | MM14572 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.89e-04 | 90 | 45 | 4 | M631 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.06e-04 | 92 | 45 | 4 | MM14951 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.19e-04 | 37 | 45 | 3 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 2.56e-04 | 39 | 45 | 3 | MM14601 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.95e-04 | 101 | 45 | 4 | M27253 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 2.98e-04 | 41 | 45 | 3 | MM15538 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.67e-04 | 44 | 45 | 3 | M26969 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 4.19e-04 | 46 | 45 | 3 | M198 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 4.68e-04 | 114 | 45 | 4 | MM14571 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 5.38e-04 | 11 | 45 | 2 | M47958 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 6.02e-04 | 52 | 45 | 3 | MM14949 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 6.73e-04 | 54 | 45 | 3 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 6.73e-04 | 54 | 45 | 3 | MM15202 | |
| Pathway | KEGG_SPLICEOSOME | 7.03e-04 | 127 | 45 | 4 | M2044 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 7.60e-04 | 13 | 45 | 2 | M39589 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 7.60e-04 | 13 | 45 | 2 | MM14952 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 7.88e-04 | 57 | 45 | 3 | M27251 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 9.61e-04 | 61 | 45 | 3 | M27103 | |
| Pathway | PID_AR_PATHWAY | 9.61e-04 | 61 | 45 | 3 | M58 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 9.61e-04 | 61 | 45 | 3 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.11e-03 | 64 | 45 | 3 | M26953 | |
| Pathway | WP_APOPTOSIS_MODULATION_BY_HSP70 | 1.48e-03 | 18 | 45 | 2 | MM15964 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.65e-03 | 19 | 45 | 2 | M47760 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 1.68e-03 | 74 | 45 | 3 | M160 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.82e-03 | 76 | 45 | 3 | MM14573 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.83e-03 | 20 | 45 | 2 | MM15061 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | PABPN1 HNRNPA3 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPL | 1.85e-03 | 724 | 45 | 8 | M16843 |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | 2.01e-03 | 21 | 45 | 2 | M14966 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 2.42e-03 | 23 | 45 | 2 | MM14953 | |
| Pathway | REACTOME_FGFR2_ALTERNATIVE_SPLICING | 3.32e-03 | 27 | 45 | 2 | M27632 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 3.57e-03 | 28 | 45 | 2 | M27254 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 3.85e-03 | 99 | 45 | 3 | MM14910 | |
| Pubmed | SFPQ BAG4 HNRNPA3 ACTN4 EWSR1 CTNND1 PUM1 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH3 HNRNPL | 9.92e-16 | 274 | 59 | 13 | 34244482 | |
| Pubmed | 1.22e-15 | 36 | 59 | 8 | 17289661 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | HOXA10 SFPQ PABPN1 HNRNPA3 ACTN4 EWSR1 RPA2 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.27e-14 | 430 | 59 | 14 | 38172120 |
| Pubmed | SFPQ PABPN1 HNRNPA3 RPA2 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH3 HNRNPL | 3.19e-14 | 136 | 59 | 10 | 26979993 | |
| Pubmed | SFPQ HNRNPA3 HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH2 HNRNPH3 HNRNPL | 7.51e-14 | 58 | 59 | 8 | 30009671 | |
| Pubmed | HOXA10 SFPQ BAG4 HNRNPA3 EWSR1 CTNND1 HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 2.44e-13 | 421 | 59 | 13 | 34650049 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | PEF1 SFPQ PABPN1 ANXA7 BAG4 HNRNPA3 EWSR1 PUM1 HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 2.64e-13 | 807 | 59 | 16 | 22681889 |
| Pubmed | SFPQ PABPN1 HNRNPA3 EWSR1 CTNND1 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH3 HNRNPL | 3.36e-13 | 244 | 59 | 11 | 29884807 | |
| Pubmed | SFPQ SRI HNRNPA3 SYP ACTN4 EWSR1 RPA2 HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPL | 3.78e-13 | 552 | 59 | 14 | 36293380 | |
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | SFPQ COL17A1 HNRNPA3 EWSR1 CTNND1 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 | 5.68e-13 | 256 | 59 | 11 | 24189400 |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | SFPQ PABPN1 HNRNPA3 EWSR1 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 6.18e-13 | 258 | 59 | 11 | 37794589 |
| Pubmed | SFPQ SRI HNRNPA3 ACTN4 EWSR1 PUM1 HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH3 HNRNPL | 1.69e-12 | 491 | 59 | 13 | 22623428 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | JUNB PEF1 SFPQ BAG4 HNRNPA3 ACTN4 EWSR1 CTNND1 PUM1 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.98e-12 | 922 | 59 | 16 | 27609421 |
| Pubmed | HNRNPA3 EWSR1 ZMIZ1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH3 HNRNPL | 2.42e-12 | 88 | 59 | 8 | 26318153 | |
| Pubmed | SFPQ SRI HNRNPA3 EWSR1 RPA2 HSPA1A HSPA1B HNRNPA1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 3.04e-12 | 399 | 59 | 12 | 35987950 | |
| Pubmed | 5.41e-12 | 11 | 59 | 5 | 21900255 | ||
| Pubmed | SFPQ PABPN1 HNRNPA3 HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 | 9.88e-12 | 241 | 59 | 10 | 23125841 | |
| Pubmed | SFPQ SRI HNRNPA3 ACTN4 EWSR1 RPA2 HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.04e-11 | 707 | 59 | 14 | 19738201 | |
| Pubmed | SFPQ HNRNPA3 HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 | 1.39e-11 | 109 | 59 | 8 | 29511296 | |
| Pubmed | 2.00e-11 | 114 | 59 | 8 | 31553912 | ||
| Pubmed | Tandem immunoprecipitation approach to identify HIV-1 Gag associated host factors. | 5.09e-11 | 16 | 59 | 5 | 24690621 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | SFPQ HNRNPA3 EWSR1 PBX2 ARID1A HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 | 9.25e-11 | 411 | 59 | 11 | 35182466 |
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | HOXA10 SFPQ PYGO2 PABPN1 HNRNPA3 PPIP5K1 ACTN4 PBX2 PUM1 HNRNPA1 HNRNPA2B1 SPRN HNRNPH1 HNRNPH3 HNRNPL | 1.12e-10 | 1021 | 59 | 15 | 26760575 |
| Pubmed | 1.63e-10 | 46 | 59 | 6 | 19928837 | ||
| Pubmed | DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation. | 1.73e-10 | 89 | 59 | 7 | 22446626 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | SFPQ PABPN1 HNRNPA3 ACTN4 PUM1 HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.76e-10 | 714 | 59 | 13 | 28302793 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | SFPQ PABPN1 BAG4 HNRNPA3 EWSR1 CTNND1 PUM1 RPA2 HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.96e-10 | 1257 | 59 | 16 | 37317656 |
| Pubmed | 2.55e-10 | 94 | 59 | 7 | 35122331 | ||
| Pubmed | A New Cellular Interactome of SARS-CoV-2 Nucleocapsid Protein and Its Biological Implications. | 2.75e-10 | 95 | 59 | 7 | 37211047 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | HOXA10 PRR12 JUNB SFPQ PABPN1 HNRNPA3 EWSR1 ARID1A RPA2 HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 2.99e-10 | 1294 | 59 | 16 | 30804502 |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | PEF1 SFPQ PABPN1 HNRNPA3 EWSR1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 RYR2 HNRNPL | 3.19e-10 | 462 | 59 | 11 | 31138677 |
| Pubmed | SFPQ HNRNPA3 EWSR1 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 3.40e-10 | 346 | 59 | 10 | 25324306 | |
| Pubmed | Proteomic dissection of the von Hippel-Lindau (VHL) interactome. | 3.43e-10 | 98 | 59 | 7 | 21942715 | |
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | SFPQ ZAN PABPN1 HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH3 HNRNPL | 4.13e-10 | 353 | 59 | 10 | 27545878 |
| Pubmed | A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis. | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 4.69e-10 | 254 | 59 | 9 | 28431233 |
| Pubmed | LINKIN, a new transmembrane protein necessary for cell adhesion. | BAG4 HNRNPA3 EWSR1 CTNND1 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 4.76e-10 | 480 | 59 | 11 | 25437307 |
| Pubmed | SFPQ HNRNPA3 EWSR1 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH3 HNRNPL | 5.76e-10 | 260 | 59 | 9 | 36199071 | |
| Pubmed | 7.29e-10 | 109 | 59 | 7 | 12226669 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | JUNB SFPQ PABPN1 ANXA7 HNRNPA3 EWSR1 CTNND1 HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 8.35e-10 | 989 | 59 | 14 | 36424410 |
| Pubmed | JUNB SFPQ PABPN1 HNRNPA3 ACTN4 RPA2 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH3 HNRNPL | 8.54e-10 | 652 | 59 | 12 | 31180492 | |
| Pubmed | SFPQ HNRNPA3 EWSR1 RPA2 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPL | 1.33e-09 | 286 | 59 | 9 | 32041737 | |
| Pubmed | SFPQ PABPN1 HNRNPA3 ACTN4 EWSR1 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPL | 1.74e-09 | 295 | 59 | 9 | 26209609 | |
| Pubmed | AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis. | HNRNPA3 CTNND1 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPL | 1.79e-09 | 200 | 59 | 8 | 35546148 |
| Pubmed | SFPQ PABPN1 HNRNPA3 EWSR1 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 2.01e-09 | 551 | 59 | 11 | 34728620 | |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | SFPQ PABPN1 ANXA7 DLG3 EWSR1 CTNND1 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPL | 2.02e-09 | 704 | 59 | 12 | 32994395 |
| Pubmed | SFPQ HNRNPA3 EWSR1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 | 2.26e-09 | 206 | 59 | 8 | 22174317 | |
| Pubmed | Proteomic analysis of complexes formed by human topoisomerase I. | 2.30e-09 | 32 | 59 | 5 | 15848144 | |
| Pubmed | SFPQ HNRNPA3 PUM1 HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 | 2.46e-09 | 425 | 59 | 10 | 21081503 | |
| Pubmed | SPOP attenuates migration and invasion of choriocarcinoma cells by promoting DHX9 degradation. | 2.51e-09 | 130 | 59 | 7 | 32905556 | |
| Pubmed | Quantitative analysis of PPT1 interactome in human neuroblastoma cells. | CTNND1 RPA2 HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 | 2.63e-09 | 210 | 59 | 8 | 26217791 |
| Pubmed | 2.65e-09 | 131 | 59 | 7 | 34551306 | ||
| Pubmed | SFPQ PABPN1 BAG4 HNRNPA3 EWSR1 HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 2.81e-09 | 725 | 59 | 12 | 27025967 | |
| Pubmed | BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sites. | 2.86e-09 | 73 | 59 | 6 | 32347575 | |
| Pubmed | 3.45e-09 | 136 | 59 | 7 | 21280222 | ||
| Pubmed | HOXA10 SFPQ PABPN1 HNRNPA3 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH3 HNRNPL | 3.50e-09 | 441 | 59 | 10 | 31239290 | |
| Pubmed | Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis. | 4.64e-09 | 3 | 59 | 3 | 23827524 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | SFPQ HNRNPA3 EWSR1 ARID1A HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH3 HNRNPL | 5.30e-09 | 605 | 59 | 11 | 28977666 |
| Pubmed | PEF1 SFPQ HNRNPA3 EWSR1 ARID1A HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH3 HNRNPL | 6.28e-09 | 615 | 59 | 11 | 31048545 | |
| Pubmed | Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin. | 6.51e-09 | 149 | 59 | 7 | 26370502 | |
| Pubmed | SFPQ PABPN1 HNRNPA3 EWSR1 PUM1 HNRNPA1 HNRNPH1 HNRNPH2 HNRNPL | 7.16e-09 | 347 | 59 | 9 | 16033648 | |
| Pubmed | 7.25e-09 | 239 | 59 | 8 | 26641092 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | SFPQ PABPN1 HNRNPA3 ACTN4 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPL | 7.39e-09 | 477 | 59 | 10 | 31300519 |
| Pubmed | SFPQ ANXA7 SRI HNRNPA3 ACTN4 CTNND1 RPA2 HNRNPA1 HNRNPA2B1 HNRNPH3 | 8.48e-09 | 484 | 59 | 10 | 31995728 | |
| Pubmed | SFPQ PABPN1 HNRNPA3 ACTN4 EWSR1 RPA2 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 9.51e-09 | 809 | 59 | 12 | 32129710 | |
| Pubmed | HOXA10 PRR12 JUNB FBN2 PYGO2 PABPN1 ZMIZ2 EWSR1 ZMIZ1 PBX2 ARID1A PUM1 RPA2 HNRNPH3 HNRNPL | 1.08e-08 | 1429 | 59 | 15 | 35140242 | |
| Pubmed | SFPQ HNRNPA3 ACTN4 CTNND1 RPA2 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.30e-08 | 660 | 59 | 11 | 32780723 | |
| Pubmed | Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. | 1.32e-08 | 258 | 59 | 8 | 21081666 | |
| Pubmed | 1.44e-08 | 261 | 59 | 8 | 33277362 | ||
| Pubmed | PRR12 COL6A3 JUNB SFPQ HNRNPA3 ACTN4 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPL | 1.47e-08 | 513 | 59 | 10 | 25798074 | |
| Pubmed | SFPQ BAG4 HNRNPA3 ACTN4 EWSR1 CTNND1 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPL | 1.52e-08 | 844 | 59 | 12 | 25963833 | |
| Pubmed | Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin. | 1.62e-08 | 170 | 59 | 7 | 16159877 | |
| Pubmed | 1.76e-08 | 172 | 59 | 7 | 26336360 | ||
| Pubmed | 1.76e-08 | 172 | 59 | 7 | 23184937 | ||
| Pubmed | HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy. | 1.85e-08 | 4 | 59 | 3 | 12945950 | |
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 1.98e-08 | 175 | 59 | 7 | 25756610 | |
| Pubmed | SFPQ PABPN1 HNRNPA3 EWSR1 CTNND1 HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPL | 2.77e-08 | 711 | 59 | 11 | 33022573 | |
| Pubmed | Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer. | 2.89e-08 | 52 | 59 | 5 | 24591637 | |
| Pubmed | 2.89e-08 | 52 | 59 | 5 | 26265008 | ||
| Pubmed | PRR12 JUNB SFPQ ZMIZ2 HNRNPA3 ACTN4 EWSR1 ARID1A RPA2 HSPA1B HNRNPA1 HNRNPA2B1 HNRNPL | 3.20e-08 | 1103 | 59 | 13 | 34189442 | |
| Pubmed | PEF1 SFPQ BAG4 HNRNPA3 EWSR1 CTNND1 RPA2 HSPA1A HNRNPA1 HNRNPH1 HNRNPH2 | 3.28e-08 | 723 | 59 | 11 | 34133714 | |
| Pubmed | SFPQ CTNNAL1 PABPN1 BAG4 HNRNPA3 EWSR1 CTNND1 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 3.72e-08 | 1335 | 59 | 14 | 29229926 | |
| Pubmed | Regulation of alternative splicing by SRrp86 and its interacting proteins. | 4.62e-08 | 57 | 59 | 5 | 14559993 | |
| Pubmed | Interaction of antiproliferative protein Tob with the CCR4-NOT deadenylase complex. | 5.34e-08 | 22 | 59 | 4 | 18377426 | |
| Pubmed | Profiling of Parkin-binding partners using tandem affinity purification. | 5.49e-08 | 203 | 59 | 7 | 24244333 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PEF1 SFPQ HNRNPA3 EWSR1 ARID1A PUM1 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH3 HNRNPL | 5.80e-08 | 954 | 59 | 12 | 36373674 |
| Pubmed | 6.45e-08 | 23 | 59 | 4 | 18320585 | ||
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | SFPQ HNRNPA3 CTNND1 HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 | 6.46e-08 | 317 | 59 | 8 | 17620599 |
| Pubmed | The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation. | SFPQ HNRNPA3 CTNND1 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH3 RYR1 HNRNPL | 6.78e-08 | 604 | 59 | 10 | 37616343 |
| Pubmed | 7.38e-08 | 212 | 59 | 7 | 23463506 | ||
| Pubmed | 7.74e-08 | 24 | 59 | 4 | 30719818 | ||
| Pubmed | COL6A1 FBN2 PUM1 HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPL | 7.78e-08 | 613 | 59 | 10 | 22268729 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PEF1 SFPQ PABPN1 HNRNPA3 ACTN4 CTNND1 PUM1 RPA2 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH3 HNRNPL | 8.32e-08 | 1425 | 59 | 14 | 30948266 |
| Pubmed | SFPQ HNRNPA3 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH3 HNRNPL | 8.79e-08 | 330 | 59 | 8 | 32529326 | |
| Pubmed | Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3. | 9.21e-08 | 332 | 59 | 8 | 30595499 | |
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 9.24e-08 | 6 | 59 | 3 | 26025922 | |
| Pubmed | 9.24e-08 | 6 | 59 | 3 | 11527400 | ||
| Pubmed | 9.24e-08 | 6 | 59 | 3 | 20159969 | ||
| Pubmed | Expression of Foxa transcription factors in the developing and adult murine prostate. | 9.24e-08 | 6 | 59 | 3 | 15389796 | |
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | PABPN1 HNRNPA3 ACTN4 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPL | 9.42e-08 | 333 | 59 | 8 | 32665550 |
| Pubmed | 9.80e-08 | 221 | 59 | 7 | 31796584 | ||
| Interaction | GLDC interactions | SFPQ BAG4 HNRNPA3 ACTN4 EWSR1 CTNND1 PUM1 RPA2 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH3 HNRNPL | 2.75e-13 | 321 | 58 | 14 | int:GLDC |
| Interaction | MIR138-1 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 3.06e-13 | 68 | 58 | 9 | int:MIR138-1 |
| Interaction | MIR9-3 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 4.02e-13 | 70 | 58 | 9 | int:MIR9-3 |
| Interaction | MIR140 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 4.59e-13 | 71 | 58 | 9 | int:MIR140 |
| Interaction | MIR20A interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 6.77e-13 | 74 | 58 | 9 | int:MIR20A |
| Interaction | MIR199A2 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 8.68e-13 | 76 | 58 | 9 | int:MIR199A2 |
| Interaction | MIR200A interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 9.81e-13 | 77 | 58 | 9 | int:MIR200A |
| Interaction | MIR98 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.11e-12 | 78 | 58 | 9 | int:MIR98 |
| Interaction | MIR206 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.25e-12 | 79 | 58 | 9 | int:MIR206 |
| Interaction | MIR1-2 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.25e-12 | 79 | 58 | 9 | int:MIR1-2 |
| Interaction | MIR143 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.40e-12 | 80 | 58 | 9 | int:MIR143 |
| Interaction | MIR145 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.57e-12 | 81 | 58 | 9 | int:MIR145 |
| Interaction | MIR106A interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.97e-12 | 83 | 58 | 9 | int:MIR106A |
| Interaction | MIR199A1 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 2.20e-12 | 84 | 58 | 9 | int:MIR199A1 |
| Interaction | MIR200B interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 2.20e-12 | 84 | 58 | 9 | int:MIR200B |
| Interaction | MIR107 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 2.46e-12 | 85 | 58 | 9 | int:MIR107 |
| Interaction | MIR18B interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 2.46e-12 | 85 | 58 | 9 | int:MIR18B |
| Interaction | MIR17 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 2.46e-12 | 85 | 58 | 9 | int:MIR17 |
| Interaction | MIR93 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 2.46e-12 | 85 | 58 | 9 | int:MIR93 |
| Interaction | MIR20B interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 2.74e-12 | 86 | 58 | 9 | int:MIR20B |
| Interaction | MIR29A interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 3.05e-12 | 87 | 58 | 9 | int:MIR29A |
| Interaction | MIR138-2 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 3.39e-12 | 88 | 58 | 9 | int:MIR138-2 |
| Interaction | MIR29C interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 3.77e-12 | 89 | 58 | 9 | int:MIR29C |
| Interaction | MIR92A2 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 4.17e-12 | 90 | 58 | 9 | int:MIR92A2 |
| Interaction | MIR1-1 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 4.17e-12 | 90 | 58 | 9 | int:MIR1-1 |
| Interaction | MIR214 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 5.65e-12 | 93 | 58 | 9 | int:MIR214 |
| Interaction | MIR19B2 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 6.23e-12 | 94 | 58 | 9 | int:MIR19B2 |
| Interaction | MIRLET7F1 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 6.23e-12 | 94 | 58 | 9 | int:MIRLET7F1 |
| Interaction | MIRLET7A2 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 7.56e-12 | 96 | 58 | 9 | int:MIRLET7A2 |
| Interaction | MIRLET7F2 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 8.32e-12 | 97 | 58 | 9 | int:MIRLET7F2 |
| Interaction | MIR21 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 8.32e-12 | 97 | 58 | 9 | int:MIR21 |
| Interaction | MIR106B interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 9.14e-12 | 98 | 58 | 9 | int:MIR106B |
| Interaction | MIR128-2 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.00e-11 | 99 | 58 | 9 | int:MIR128-2 |
| Interaction | MIRLET7D interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.20e-11 | 101 | 58 | 9 | int:MIRLET7D |
| Interaction | MIR25 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.20e-11 | 101 | 58 | 9 | int:MIR25 |
| Interaction | MIRLET7A3 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.32e-11 | 102 | 58 | 9 | int:MIRLET7A3 |
| Interaction | MIR15B interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.44e-11 | 103 | 58 | 9 | int:MIR15B |
| Interaction | MIR7-1 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.44e-11 | 103 | 58 | 9 | int:MIR7-1 |
| Interaction | RBM45 interactions | SFPQ PABPN1 HNRNPA3 EWSR1 RPA2 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH3 HNRNPL | 1.54e-11 | 207 | 58 | 11 | int:RBM45 |
| Interaction | MIR19B1 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.57e-11 | 104 | 58 | 9 | int:MIR19B1 |
| Interaction | MIR34A interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.57e-11 | 104 | 58 | 9 | int:MIR34A |
| Interaction | MIRLET7E interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.87e-11 | 106 | 58 | 9 | int:MIRLET7E |
| Interaction | MIRLET7A1 interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 2.22e-11 | 108 | 58 | 9 | int:MIRLET7A1 |
| Interaction | MIR122 interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 2.63e-11 | 71 | 58 | 8 | int:MIR122 |
| Interaction | MIR29B2 interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 2.63e-11 | 71 | 58 | 8 | int:MIR29B2 |
| Interaction | MIR29B1 interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 3.31e-11 | 73 | 58 | 8 | int:MIR29B1 |
| Interaction | HNRNPAB interactions | SFPQ HOXD4 PABPN1 HNRNPA3 ACTN4 EWSR1 RPA2 HSPA1A HNRNPA1 HNRNPA2B1 AR HNRNPH1 HNRNPL | 3.38e-11 | 371 | 58 | 13 | int:HNRNPAB |
| Interaction | MIRLET7I interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 3.63e-11 | 114 | 58 | 9 | int:MIRLET7I |
| Interaction | MIR15A interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 4.14e-11 | 75 | 58 | 8 | int:MIR15A |
| Interaction | MIRLET7G interactions | SFPQ HNRNPA3 PUM1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 4.60e-11 | 117 | 58 | 9 | int:MIRLET7G |
| Interaction | MIR7-3 interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 4.61e-11 | 76 | 58 | 8 | int:MIR7-3 |
| Interaction | MIR16-1 interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 4.61e-11 | 76 | 58 | 8 | int:MIR16-1 |
| Interaction | MIR429 interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 4.61e-11 | 76 | 58 | 8 | int:MIR429 |
| Interaction | MIR9-2 interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 5.14e-11 | 77 | 58 | 8 | int:MIR9-2 |
| Interaction | MIR92A1 interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 5.71e-11 | 78 | 58 | 8 | int:MIR92A1 |
| Interaction | MIR451A interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 5.71e-11 | 78 | 58 | 8 | int:MIR451A |
| Interaction | MIR222 interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 6.34e-11 | 79 | 58 | 8 | int:MIR222 |
| Interaction | MIR34C interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 6.34e-11 | 79 | 58 | 8 | int:MIR34C |
| Interaction | CUL2 interactions | PABPN1 BAG4 HNRNPA3 DLG3 EWSR1 ARID1A RPA2 HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 AR HNRNPH1 HNRNPH2 HNRNPH3 | 7.94e-11 | 591 | 58 | 15 | int:CUL2 |
| Interaction | MIR31 interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.05e-10 | 84 | 58 | 8 | int:MIR31 |
| Interaction | MIR7-2 interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.05e-10 | 84 | 58 | 8 | int:MIR7-2 |
| Interaction | MIR9-1 interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.15e-10 | 85 | 58 | 8 | int:MIR9-1 |
| Interaction | MIR16-2 interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.15e-10 | 85 | 58 | 8 | int:MIR16-2 |
| Interaction | MIR141 interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.53e-10 | 88 | 58 | 8 | int:MIR141 |
| Interaction | MIR221 interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.84e-10 | 90 | 58 | 8 | int:MIR221 |
| Interaction | RNF43 interactions | SFPQ BAG4 HNRNPA3 ANKRD26 CTNND1 ARID1A HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPL | 1.92e-10 | 427 | 58 | 13 | int:RNF43 |
| Interaction | MIR200C interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 2.01e-10 | 91 | 58 | 8 | int:MIR200C |
| Interaction | MIR155 interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 2.20e-10 | 92 | 58 | 8 | int:MIR155 |
| Interaction | MIR128-1 interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 2.20e-10 | 92 | 58 | 8 | int:MIR128-1 |
| Interaction | HNRNPD interactions | SFPQ PABPN1 HNRNPA3 ACTN4 EWSR1 ZMIZ1 RPA2 HSPA1A HNRNPA1 HNRNPA2B1 AR HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 2.30e-10 | 638 | 58 | 15 | int:HNRNPD |
| Interaction | MIR205 interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 2.40e-10 | 93 | 58 | 8 | int:MIR205 |
| Interaction | DCUN1D1 interactions | BAG4 HNRNPA3 EWSR1 RPA2 HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 | 3.23e-10 | 275 | 58 | 11 | int:DCUN1D1 |
| Interaction | MATR3 interactions | SFPQ HNRNPA3 EWSR1 CTNND1 PUM1 RPA2 HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 AR HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 3.31e-10 | 655 | 58 | 15 | int:MATR3 |
| Interaction | MIRLET7C interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 3.38e-10 | 97 | 58 | 8 | int:MIRLET7C |
| Interaction | MIR363 interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 3.38e-10 | 97 | 58 | 8 | int:MIR363 |
| Interaction | RBM14 interactions | PEF1 SFPQ BAG4 HNRNPA3 RPA2 HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 AR HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 3.90e-10 | 553 | 58 | 14 | int:RBM14 |
| Interaction | TRIM31 interactions | HOXA10 SFPQ BAG4 HNRNPA3 EWSR1 CTNND1 HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 4.07e-10 | 454 | 58 | 13 | int:TRIM31 |
| Interaction | MIR19A interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 4.32e-10 | 100 | 58 | 8 | int:MIR19A |
| Interaction | MIRLET7B interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 4.68e-10 | 101 | 58 | 8 | int:MIRLET7B |
| Interaction | UBQLN2 interactions | PEF1 COL17A1 ANXA7 BAG4 SRI HNRNPA3 EWSR1 RPA2 HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 RYR1 | 5.21e-10 | 797 | 58 | 16 | int:UBQLN2 |
| Interaction | CUL5 interactions | PABPN1 ANXA7 BAG4 HNRNPA3 EWSR1 RPA2 HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 5.39e-10 | 567 | 58 | 14 | int:CUL5 |
| Interaction | MIR34B interactions | SFPQ HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 9.30e-10 | 110 | 58 | 8 | int:MIR34B |
| Interaction | SOX2 interactions | PRR12 COL6A1 COL6A3 PYGO2 PABPN1 ZMIZ2 ANXA7 HNRNPA3 ANKRD26 ACTN4 EWSR1 CTNND1 PBX2 ARID1A RPA2 HNRNPA2B1 HNRNPH1 HNRNPH2 RYR1 HNRNPL | 1.13e-09 | 1422 | 58 | 20 | int:SOX2 |
| Interaction | ACTN4 interactions | BMP7 COL17A1 PABPN1 ACTN4 ARID1A RPA2 HSPA1A HNRNPA1 HNRNPA2B1 AR HNRNPH1 HNRNPL | 1.24e-09 | 400 | 58 | 12 | int:ACTN4 |
| Interaction | MIR18A interactions | 1.58e-09 | 73 | 58 | 7 | int:MIR18A | |
| Interaction | KHDRBS2 interactions | 3.32e-09 | 129 | 58 | 8 | int:KHDRBS2 | |
| Interaction | MIR10B interactions | 3.62e-09 | 82 | 58 | 7 | int:MIR10B | |
| Interaction | ITGA4 interactions | SFPQ SRI HNRNPA3 ACTN4 EWSR1 PUM1 HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH3 HNRNPL | 3.89e-09 | 547 | 58 | 13 | int:ITGA4 |
| Interaction | DHX9 interactions | SFPQ CTNNAL1 PABPN1 HNRNPA3 ACTN4 EWSR1 RPA2 HSPA1A HNRNPA1 HNRNPA2B1 AR HNRNPH1 HNRNPH3 HNRNPL | 3.96e-09 | 662 | 58 | 14 | int:DHX9 |
| Interaction | USP48 interactions | SFPQ SRI HNRNPA3 SYP ACTN4 EWSR1 RPA2 HSPA1A HNRNPA1 HNRNPA2B1 AR HNRNPH1 HNRNPH2 HNRNPL | 4.44e-09 | 668 | 58 | 14 | int:USP48 |
| Interaction | TNIP2 interactions | JUNB PEF1 SFPQ BAG4 HNRNPA3 ACTN4 EWSR1 CTNND1 PUM1 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 6.69e-09 | 952 | 58 | 16 | int:TNIP2 |
| Interaction | COPS5 interactions | HOXA10 SFPQ PABPN1 ANXA7 BAG4 HNRNPA3 EWSR1 PUM1 RPA2 HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 7.25e-09 | 1102 | 58 | 17 | int:COPS5 |
| Interaction | VCAM1 interactions | SFPQ SRI HNRNPA3 ACTN4 EWSR1 HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH3 HNRNPL | 8.54e-09 | 475 | 58 | 12 | int:VCAM1 |
| Interaction | PHB1 interactions | COL6A1 SFPQ PABPN1 BAG4 HNRNPA3 EWSR1 ARID1A RPA2 HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 AR HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 9.61e-09 | 1123 | 58 | 17 | int:PHB1 |
| Interaction | PLOD1 interactions | COL6A1 COL21A1 HNRNPA3 RPA2 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPL | 9.88e-09 | 292 | 58 | 10 | int:PLOD1 |
| Interaction | FN1 interactions | SFPQ SRI HNRNPA3 ACTN4 EWSR1 RPA2 HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 AR HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.11e-08 | 848 | 58 | 15 | int:FN1 |
| Interaction | ERG interactions | PRR12 SFPQ PYGO2 ARID1A HNRNPA1 HNRNPA2B1 AR HNRNPH1 HNRNPH3 | 1.41e-08 | 223 | 58 | 9 | int:ERG |
| Interaction | SF1 interactions | SFPQ BAG4 EWSR1 RPA2 HSPA1A HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPL | 1.45e-08 | 304 | 58 | 10 | int:SF1 |
| Interaction | FUBP1 interactions | SFPQ PABPN1 HNRNPA3 PUM1 RPA2 HNRNPA1 HNRNPA2B1 AR HNRNPH3 HNRNPL | 1.69e-08 | 309 | 58 | 10 | int:FUBP1 |
| Interaction | FOXC1 interactions | 1.71e-08 | 228 | 58 | 9 | int:FOXC1 | |
| GeneFamily | RNA binding motif containing | SFPQ PABPN1 HNRNPA3 EWSR1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.85e-10 | 213 | 48 | 10 | 725 |
| GeneFamily | Collagens | 6.57e-06 | 46 | 48 | 4 | 490 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.07e-05 | 3 | 48 | 2 | 287 | |
| GeneFamily | Zinc fingers MIZ-type | 1.44e-04 | 7 | 48 | 2 | 85 | |
| GeneFamily | Heat shock 70kDa proteins | 9.15e-04 | 17 | 48 | 2 | 583 | |
| GeneFamily | Forkhead boxes | 5.81e-03 | 43 | 48 | 2 | 508 | |
| GeneFamily | HOXL subclass homeoboxes | 8.41e-03 | 52 | 48 | 2 | 518 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 8.73e-03 | 53 | 48 | 2 | 103 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.23e-02 | 181 | 48 | 3 | 694 | |
| GeneFamily | EF-hand domain containing | 2.03e-02 | 219 | 48 | 3 | 863 | |
| Coexpression | FAN_OVARY_CL15_SMALL_ANTRAL_FOLLICLE_GRANULOSA_CELL | SFPQ CTNNAL1 PABPN1 SRI EWSR1 CTNND1 PUM1 HSPA1A HSPA1B HNRNPA1 HNRNPA2B1 HNRNPH1 | 1.70e-08 | 644 | 59 | 12 | M41717 |
| Coexpression | FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL | COL6A1 SFPQ CTNNAL1 HNRNPA3 EWSR1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH3 | 1.71e-07 | 380 | 59 | 9 | M41703 |
| Coexpression | KIM_WT1_TARGETS_8HR_UP | 2.08e-06 | 167 | 59 | 6 | M8857 | |
| Coexpression | NABA_COLLAGENS | 2.94e-06 | 44 | 59 | 4 | M3005 | |
| Coexpression | GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_DN | 3.65e-06 | 184 | 59 | 6 | M6593 | |
| Coexpression | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN | 3.65e-06 | 184 | 59 | 6 | M19988 | |
| Coexpression | HEVNER_TELENCEPHALON_MENINGEAL_CELLS | 4.93e-06 | 50 | 59 | 4 | MM403 | |
| Coexpression | HAY_BONE_MARROW_PRO_B | 5.36e-06 | 304 | 59 | 7 | M39208 | |
| Coexpression | GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_UP | 5.89e-06 | 200 | 59 | 6 | M8068 | |
| Coexpression | GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN | 5.89e-06 | 200 | 59 | 6 | M327 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | HOXA10 JUNB CTNNAL1 COL17A1 SRI PPIP5K1 ARID1A HNRNPA2B1 HNRNPH1 HNRNPH3 | 1.69e-05 | 843 | 59 | 10 | M2356 |
| Coexpression | NABA_CORE_MATRISOME | 3.57e-05 | 275 | 59 | 6 | M5884 | |
| Coexpression | KIM_WT1_TARGETS_12HR_UP | 3.64e-05 | 166 | 59 | 5 | M15535 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5 | 5.13e-05 | 32 | 59 | 3 | MM1278 | |
| Coexpression | WANG_MLL_TARGETS | 5.18e-05 | 294 | 59 | 6 | M2456 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | SFPQ PABPN1 COL21A1 HNRNPA3 ANKRD26 EWSR1 RPA2 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPL | 5.34e-05 | 1394 | 59 | 12 | M9585 |
| Coexpression | WANG_MLL_TARGETS | 6.46e-05 | 306 | 59 | 6 | MM1076 | |
| Coexpression | GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_UP | 8.61e-05 | 199 | 59 | 5 | M7656 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_DN | 8.61e-05 | 199 | 59 | 5 | M8313 | |
| Coexpression | DORN_ADENOVIRUS_INFECTION_32HR_DN | 8.64e-05 | 38 | 59 | 3 | M15590 | |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_NEGATIVE | 8.66e-05 | 637 | 59 | 8 | M41118 | |
| Coexpression | GSE31082_DN_VS_DP_THYMOCYTE_DN | 8.82e-05 | 200 | 59 | 5 | M5055 | |
| Coexpression | GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_DN | 8.82e-05 | 200 | 59 | 5 | M5096 | |
| Coexpression | GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_UP | 8.82e-05 | 200 | 59 | 5 | M9073 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDC_DN | 8.82e-05 | 200 | 59 | 5 | M3777 | |
| Coexpression | GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP | 8.82e-05 | 200 | 59 | 5 | M5787 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP | 8.82e-05 | 200 | 59 | 5 | M5777 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_UP | 8.82e-05 | 200 | 59 | 5 | M5779 | |
| Coexpression | DORN_ADENOVIRUS_INFECTION_48HR_DN | 9.35e-05 | 39 | 59 | 3 | M7375 | |
| Coexpression | CUI_DEVELOPING_HEART_C5_VALVAR_CELL | 9.90e-05 | 205 | 59 | 5 | M39302 | |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN | 1.22e-04 | 669 | 59 | 8 | M18635 | |
| Coexpression | VANASSE_BCL2_TARGETS_UP | 1.25e-04 | 43 | 59 | 3 | MM799 | |
| Coexpression | NABA_COLLAGENS | 1.25e-04 | 43 | 59 | 3 | MM17060 | |
| Coexpression | TRAVAGLINI_LUNG_BASOPHIL_MAST_2_CELL | 1.32e-04 | 503 | 59 | 7 | M41690 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 1.42e-04 | 117 | 59 | 4 | M39300 | |
| Coexpression | ZHANG_UTERUS_C2_SECRETORY_STROMAL3_RAMP3_HIGH_CELL | 1.66e-04 | 229 | 59 | 5 | MM16607 | |
| Coexpression | WESTON_VEGFA_TARGETS_6HR | 1.97e-04 | 50 | 59 | 3 | M1521 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | 2.03e-04 | 721 | 59 | 8 | M1999 | |
| Coexpression | KAYO_AGING_MUSCLE_UP | 2.15e-04 | 242 | 59 | 5 | M16050 | |
| Coexpression | KRISHNAN_FURIN_TARGETS_UP | 2.22e-04 | 10 | 59 | 2 | MM1243 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_KIDNEY_COLLECTING_DUCT_PRINCIPAL_CELL_AGEING | 2.55e-04 | 394 | 59 | 6 | MM3724 | |
| Coexpression | ZHANG_UTERUS_C6_ENDOTHELIAL_PLVAP_HIGH_CELL | 2.60e-04 | 137 | 59 | 4 | MM16612 | |
| Coexpression | NABA_CORE_MATRISOME | 3.55e-04 | 270 | 59 | 5 | MM17057 | |
| Coexpression | TRAVAGLINI_LUNG_BRONCHIAL_VESSEL_2_CELL | 3.68e-04 | 272 | 59 | 5 | M41669 | |
| Coexpression | JIANG_MELANOMA_TRM3_CD8 | 3.78e-04 | 424 | 59 | 6 | M48967 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_1_DN | 4.09e-04 | 64 | 59 | 3 | M2237 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 4.16e-04 | 155 | 59 | 4 | M39246 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 4.17e-04 | 432 | 59 | 6 | M41149 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 4.29e-04 | 65 | 59 | 3 | M39309 | |
| Coexpression | FAN_OVARY_CL11_MURAL_GRANULOSA_CELL | 4.82e-04 | 444 | 59 | 6 | M41713 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FBN1_FAP_CELLS | 4.84e-04 | 289 | 59 | 5 | M41750 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | 5.05e-04 | 448 | 59 | 6 | MM1044 | |
| Coexpression | QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE | 5.24e-04 | 294 | 59 | 5 | M40873 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_PROLIFERATING_BASAL_CELLS | 5.33e-04 | 70 | 59 | 3 | M40002 | |
| Coexpression | CADWELL_ATG16L1_TARGETS_DN | 5.55e-04 | 71 | 59 | 3 | M12482 | |
| Coexpression | MARTENS_TRETINOIN_RESPONSE_DN | SFPQ PABPN1 HNRNPA3 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH3 HNRNPL | 5.58e-04 | 839 | 59 | 8 | M2099 |
| Coexpression | FAN_OVARY_CL6_PUTATIVE_EARLY_ATRETIC_FOLLICLE_THECAL_CELL_2 | 5.74e-04 | 300 | 59 | 5 | M41708 | |
| Coexpression | FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP | 5.86e-04 | 16 | 59 | 2 | MM559 | |
| Coexpression | CADWELL_ATG16L1_TARGETS_DN | 6.27e-04 | 74 | 59 | 3 | MM768 | |
| Coexpression | KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN | 6.63e-04 | 17 | 59 | 2 | M1776 | |
| Coexpression | ZHANG_UTERUS_C1_PROLIFERATIVE_STROMAL1_MGP_HIGH_CELL | 6.65e-04 | 310 | 59 | 5 | MM16608 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS | 7.12e-04 | 871 | 59 | 8 | MM1005 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_EARLY_SUPRABASAL_CELLS | 7.59e-04 | 79 | 59 | 3 | M40003 | |
| Coexpression | LEI_MYB_TARGETS | 8.00e-04 | 323 | 59 | 5 | M863 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 8.47e-04 | 685 | 59 | 7 | MM3782 | |
| Coexpression | BUSSLINGER_GASTRIC_X_CELLS | 9.09e-04 | 191 | 59 | 4 | M40019 | |
| Coexpression | LAMB_CCND1_TARGETS | 9.22e-04 | 20 | 59 | 2 | M2935 | |
| Coexpression | CUI_DEVELOPING_HEART_VASCULAR_ENDOTHELIAL_CELL | 9.45e-04 | 193 | 59 | 4 | M39321 | |
| Coexpression | LEF1_UP.V1_UP | 9.64e-04 | 194 | 59 | 4 | M2905 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 9.64e-04 | 194 | 59 | 4 | M39122 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | SFPQ PABPN1 ANXA7 SRI HNRNPA3 EWSR1 ARID1A HNRNPA2B1 HNRNPH1 | 9.80e-04 | 1144 | 59 | 9 | MM3843 |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_MESENCHYMAL_STEM_CELL_AGEING | 1.00e-03 | 196 | 59 | 4 | MM3746 | |
| Coexpression | GESERICK_TERT_TARGETS_DN | 1.02e-03 | 21 | 59 | 2 | M15891 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C2 | 1.02e-03 | 21 | 59 | 2 | M4767 | |
| Coexpression | GESERICK_TERT_TARGETS_DN | 1.02e-03 | 21 | 59 | 2 | MM1085 | |
| Coexpression | GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_UP | 1.02e-03 | 197 | 59 | 4 | M3480 | |
| Coexpression | GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_UP | 1.04e-03 | 198 | 59 | 4 | M9534 | |
| Coexpression | GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_DN | 1.04e-03 | 198 | 59 | 4 | M5701 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | 1.04e-03 | 1399 | 59 | 10 | M535 | |
| Coexpression | GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_UP | 1.06e-03 | 199 | 59 | 4 | M3391 | |
| Coexpression | GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_DN | 1.06e-03 | 199 | 59 | 4 | M6648 | |
| Coexpression | GSE360_CTRL_VS_L_DONOVANI_MAC_DN | 1.06e-03 | 199 | 59 | 4 | M5159 | |
| Coexpression | GSE17721_CTRL_VS_LPS_24H_BMDC_UP | 1.06e-03 | 199 | 59 | 4 | M3703 | |
| Coexpression | GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_UP | 1.06e-03 | 199 | 59 | 4 | M4158 | |
| Coexpression | ZHONG_PFC_C4_UNKNOWN_INP | 1.07e-03 | 89 | 59 | 3 | M39084 | |
| Coexpression | GSE14308_TH1_VS_TH17_DN | 1.08e-03 | 200 | 59 | 4 | M3374 | |
| Coexpression | GSE14308_TH2_VS_INDUCED_TREG_DN | 1.08e-03 | 200 | 59 | 4 | M3367 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_UP | 1.08e-03 | 200 | 59 | 4 | M9640 | |
| Coexpression | GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_DN | 1.08e-03 | 200 | 59 | 4 | M5364 | |
| Coexpression | GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP | 1.08e-03 | 200 | 59 | 4 | M7917 | |
| Coexpression | GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_UP | 1.08e-03 | 200 | 59 | 4 | M8216 | |
| Coexpression | HALLMARK_APICAL_JUNCTION | 1.08e-03 | 200 | 59 | 4 | M5915 | |
| Coexpression | GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_DN | 1.08e-03 | 200 | 59 | 4 | M3497 | |
| Coexpression | GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_UP | 1.08e-03 | 200 | 59 | 4 | M8514 | |
| Coexpression | GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_UP | 1.08e-03 | 200 | 59 | 4 | M8868 | |
| Coexpression | GSE7852_TREG_VS_TCONV_FAT_DN | 1.08e-03 | 200 | 59 | 4 | M5735 | |
| Coexpression | GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_UP | 1.08e-03 | 200 | 59 | 4 | M5783 | |
| Coexpression | GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP | 1.08e-03 | 200 | 59 | 4 | M6092 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_UP | 1.08e-03 | 200 | 59 | 4 | M3869 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN | 1.08e-03 | 200 | 59 | 4 | M7350 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.80e-09 | 197 | 59 | 7 | 9af431323da6d099459b7360af40e5df998cffbd | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.08e-09 | 198 | 59 | 7 | a883e25cb7a78b2ecfb15cef4633bdd02dfafb12 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.37e-09 | 199 | 59 | 7 | c007cd51577e31553395ceaed70ad447e5854546 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuroepithelial-Proteoglycan-expressing_cell|3m / Sample Type, Dataset, Time_group, and Cell type. | 8.66e-09 | 200 | 59 | 7 | 94ef227b2162ba77af33b8cc8aaa4a7e3bdf79a7 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuroepithelial|3m / Sample Type, Dataset, Time_group, and Cell type. | 8.66e-09 | 200 | 59 | 7 | 429028c3112d279b26abf3296e01b1884b4b7fcb | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-07 | 176 | 59 | 6 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-07 | 176 | 59 | 6 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 1.68e-07 | 185 | 59 | 6 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| ToppCell | Fibroblast-C|World / shred on cell class and cell subclass (v4) | 1.90e-07 | 189 | 59 | 6 | 58e0400fbab5a0755504275aef5cf7986149abab | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-07 | 192 | 59 | 6 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-07 | 192 | 59 | 6 | f053b89bfd6048c227667ff01c38df7c51d8a496 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.35e-07 | 196 | 59 | 6 | cbfe01ba8071864e19b37028236ae35789f630fe | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-07 | 196 | 59 | 6 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | 368C|World / Donor, Lineage, Cell class and subclass (all cells) | 2.43e-07 | 197 | 59 | 6 | f41211923938e5d7bfe6bf24f604ab386f17ef10 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.50e-07 | 198 | 59 | 6 | a1c8e5c332336823c47c04e56b6d7bc8f057c9da | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.57e-07 | 199 | 59 | 6 | 30ab0750d51f168b18c434c974d24a4e70f29cc7 | |
| ToppCell | 15-Airway|15 / Age, Tissue, Lineage and Cell class | 2.65e-07 | 200 | 59 | 6 | ba4b8d5becf81351901c2ecac74ffa28e29586f3 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.03e-06 | 136 | 59 | 5 | 3e13dc0634f3b05e9f9e6c3193f843f62e603b78 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.03e-06 | 136 | 59 | 5 | 0185486c39700dd2f72d79be6d283494dd8379c9 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.08e-06 | 170 | 59 | 5 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.08e-06 | 170 | 59 | 5 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 3.36e-06 | 173 | 59 | 5 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.86e-06 | 178 | 59 | 5 | e5e4742e35c3d90f82b830d77bdbdc45828c7deb | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.07e-06 | 180 | 59 | 5 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.07e-06 | 180 | 59 | 5 | e9785ac2806103f725f5a5208495826354ec6e22 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.07e-06 | 180 | 59 | 5 | 44988c34861df359a68376500c42a64fbcc4b431 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.30e-06 | 182 | 59 | 5 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.42e-06 | 183 | 59 | 5 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.42e-06 | 183 | 59 | 5 | f20b0d71f857ac35868fd80531050ad8b6091716 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-06 | 185 | 59 | 5 | 01bbe1e09f9ccae837a03ea2cdd168fa10800942 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.91e-06 | 187 | 59 | 5 | 6820bfbe552ea5e62cfe699687b051a17d9fda61 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 4.91e-06 | 187 | 59 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-06 | 188 | 59 | 5 | e54e09d34e263d5709c337914809e61e74e20591 | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 5.04e-06 | 188 | 59 | 5 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-06 | 188 | 59 | 5 | 7fc9810ab14354cb512e2b1285562009c10203f5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.30e-06 | 190 | 59 | 5 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.30e-06 | 190 | 59 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.30e-06 | 190 | 59 | 5 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 5.30e-06 | 190 | 59 | 5 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.30e-06 | 190 | 59 | 5 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.30e-06 | 190 | 59 | 5 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.44e-06 | 191 | 59 | 5 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.44e-06 | 191 | 59 | 5 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.44e-06 | 191 | 59 | 5 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.44e-06 | 191 | 59 | 5 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.44e-06 | 191 | 59 | 5 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.44e-06 | 191 | 59 | 5 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.58e-06 | 192 | 59 | 5 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-06 | 192 | 59 | 5 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.58e-06 | 192 | 59 | 5 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-06 | 192 | 59 | 5 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-06 | 192 | 59 | 5 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.58e-06 | 192 | 59 | 5 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.72e-06 | 193 | 59 | 5 | 68089ba4123e2f9bea9aae0023a844b5a57bfc0e | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.72e-06 | 193 | 59 | 5 | 164cc8d51a67c2df3112338acbb1f93c5f838376 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 5.72e-06 | 193 | 59 | 5 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.72e-06 | 193 | 59 | 5 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.72e-06 | 193 | 59 | 5 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.87e-06 | 194 | 59 | 5 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.87e-06 | 194 | 59 | 5 | 88a2dfba7d16cf52ecbc3d8c28ff82450c1bb13a | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 6.01e-06 | 195 | 59 | 5 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-06 | 196 | 59 | 5 | 66d76249bd2770cdddff2c1fe59a016e95da2124 | |
| ToppCell | LAM-Mesenchyme|LAM / Condition, Lineage and Cell class | 6.17e-06 | 196 | 59 | 5 | e7918b0cd5eeb675012f871f43f4388471845035 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.17e-06 | 196 | 59 | 5 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-06 | 196 | 59 | 5 | 9bd4c146fc7555e32adfa393b3a07846eb826d25 | |
| ToppCell | LAM-Mesenchyme-Mesenchyme|LAM / Condition, Lineage and Cell class | 6.17e-06 | 196 | 59 | 5 | 4590fb157797a68dca4295e203702bbae279cd03 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.17e-06 | 196 | 59 | 5 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | distal-mesenchymal-Vascular_Smooth_Muscle-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.32e-06 | 197 | 59 | 5 | da653dc7d216e202f390e5ab0245f243e3ed213b | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.32e-06 | 197 | 59 | 5 | 6668f0da54f3bf96769275e668cd57e00b8a5ef9 | |
| ToppCell | facs-Trachea-3m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.32e-06 | 197 | 59 | 5 | e77016d64b1cac9825fec7cfe5071f1567401187 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.32e-06 | 197 | 59 | 5 | 7c275a2ac24a9a4f83fceda93a067e754837102f | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 6.32e-06 | 197 | 59 | 5 | 58b957efd006f43c2fe55071d5c6d06c2e367e72 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.32e-06 | 197 | 59 | 5 | 888f3b14133e078570ce4ad73d9a9ee3137f9cac | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.32e-06 | 197 | 59 | 5 | ad6c200a193a15360d17463e18a465ce1b90b8da | |
| ToppCell | facs-Trachea-nan-3m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-06 | 197 | 59 | 5 | 0353d925ee4b7aefc2c51b5fab873f465cdf9ebc | |
| ToppCell | 11.5-Airway-Mesenchymal|Airway / Age, Tissue, Lineage and Cell class | 6.48e-06 | 198 | 59 | 5 | fe08709d043d927988b1bb262c766b0b572fc927 | |
| ToppCell | 11.5-Distal-Mesenchymal|Distal / Age, Tissue, Lineage and Cell class | 6.48e-06 | 198 | 59 | 5 | 5c606d881f151404287d9b43c9490e9bb486ef54 | |
| ToppCell | distal-2-mesenchymal-Vascular_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.48e-06 | 198 | 59 | 5 | ce05ede69c167b2294630709bb0c223483a6ef75 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.48e-06 | 198 | 59 | 5 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.48e-06 | 198 | 59 | 5 | ebceb11f50b8a6ebb7629fdbd3d31fb131ace6fd | |
| ToppCell | 3'-GW_trimst-2|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.48e-06 | 198 | 59 | 5 | cf9861bc14737f2dc72e50222159e0180a6d3e5c | |
| ToppCell | Healthy_Control-Myeloid-Macrophages-FCN1+SPP1+|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 6.48e-06 | 198 | 59 | 5 | aa90326b82e21de37af5642df6a70a8b21af7f04 | |
| ToppCell | 10x_3'_v3|World / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.48e-06 | 198 | 59 | 5 | aabb8e9b162ae4cb26ea860c99decdbb51e379e1 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.48e-06 | 198 | 59 | 5 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-06 | 198 | 59 | 5 | daf367b699726286f0f0f7b4f3a6cf70c462fbeb | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.48e-06 | 198 | 59 | 5 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 6.64e-06 | 199 | 59 | 5 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.64e-06 | 199 | 59 | 5 | 84545ced0c792bc77980a50d65e484eab648d47e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.64e-06 | 199 | 59 | 5 | 36c1deac7ef0f9ebde6b2f7a63f7daa03d8c139a | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 6.64e-06 | 199 | 59 | 5 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.64e-06 | 199 | 59 | 5 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.64e-06 | 199 | 59 | 5 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.80e-06 | 200 | 59 | 5 | 4234bdc70a9941d4bf77148d75bd271e0c114b88 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 6.80e-06 | 200 | 59 | 5 | eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.80e-06 | 200 | 59 | 5 | a603e8a999612d523bbce9d0feca9296d4a24c97 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.80e-06 | 200 | 59 | 5 | 3dacd0afe69bc16bb33336ea9ea99a9cd47731d9 | |
| ToppCell | distal-mesenchymal|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.80e-06 | 200 | 59 | 5 | b54137a4545690f51e154bb05964eaa650c3ca8e | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.80e-06 | 200 | 59 | 5 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | medial-mesenchymal-Airway_Smooth_Muscle|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.80e-06 | 200 | 59 | 5 | c1d9748aaae489d26e24602a5dcbe7f5fa9a5548 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.80e-06 | 200 | 59 | 5 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| Computational | Genes in the cancer module 32. | 3.47e-06 | 241 | 42 | 8 | MODULE_32 | |
| Computational | Neighborhood of DDX5 | 1.15e-04 | 65 | 42 | 4 | GCM_DDX5 | |
| Computational | RNA splicing. | 1.15e-04 | 65 | 42 | 4 | MODULE_183 | |
| Computational | Neighborhood of PRKAG1 | 2.15e-04 | 224 | 42 | 6 | MORF_PRKAG1 | |
| Computational | Neighborhood of CDC10 | 2.45e-04 | 146 | 42 | 5 | MORF_CDC10 | |
| Computational | Neighborhood of RAD54L | 7.23e-04 | 105 | 42 | 4 | MORF_RAD54L | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.57e-04 | 50 | 42 | 3 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_STRESS | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.57e-04 | 50 | 42 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_5_STRESS | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.57e-04 | 50 | 42 | 3 | GAVISH_3CA_METAPROGRAM_MACROPHAGES_STRESS_HSP | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.57e-04 | 50 | 42 | 3 | GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_STRESS_HSP | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.57e-04 | 50 | 42 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_STRESS | |
| Computational | Neighborhood of DENR | 1.01e-03 | 51 | 42 | 3 | GNF2_DENR | |
| Computational | Neighborhood of PHB | 1.39e-03 | 125 | 42 | 4 | MORF_PHB | |
| Computational | Neighborhood of PPP2CA | 1.56e-03 | 129 | 42 | 4 | MORF_PPP2CA | |
| Computational | Adhesion molecules. | 2.16e-03 | 141 | 42 | 4 | MODULE_122 | |
| Computational | Neighborhood of RBBP6 | 2.53e-03 | 70 | 42 | 3 | GNF2_RBBP6 | |
| Computational | Spinal cord (neuro-development) genes. | 2.56e-03 | 360 | 42 | 6 | MODULE_12 | |
| Computational | Neighborhood of DDB1 | 2.57e-03 | 246 | 42 | 5 | MORF_DDB1 | |
| Computational | Neighborhood of CDK2 | 2.74e-03 | 72 | 42 | 3 | MORF_CDK2 | |
| Drug | AC1L1AUZ | HNRNPA3 DLG3 EWSR1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 2.62e-10 | 157 | 59 | 9 | CID000001160 |
| Drug | AC1NRA5C | HNRNPA3 EWSR1 HNRNPA1 HNRNPA2B1 HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 1.58e-08 | 174 | 59 | 8 | CID005287709 |
| Drug | bromovanin | 3.81e-08 | 127 | 59 | 7 | ctd:C515564 | |
| Drug | SK&F 83959 | 1.37e-07 | 153 | 59 | 7 | ctd:C080703 | |
| Drug | AC1L1B55 | JUNB HNRNPA3 EWSR1 HNRNPA1 HNRNPA2B1 AR HNRNPH1 HNRNPH2 HNRNPH3 HNRNPL | 2.36e-07 | 454 | 59 | 10 | CID000001287 |
| Drug | genistein | HOXA10 COL6A3 JUNB HNRNPA3 EWSR1 HNRNPA1 HNRNPA2B1 AR HNRNPH1 HNRNPH2 HNRNPH3 RYR1 RYR2 HNRNPL | 7.23e-07 | 1117 | 59 | 14 | CID005280961 |
| Drug | BAPN | 1.12e-06 | 71 | 59 | 5 | CID000001647 | |
| Drug | DMSe | 1.19e-06 | 132 | 59 | 6 | CID000020796 | |
| Drug | isodesmosine | 1.57e-06 | 33 | 59 | 4 | CID000013811 | |
| Drug | GK-101 | 2.25e-06 | 36 | 59 | 4 | CID000161853 | |
| Drug | 2,3,6,2',3',6'-hexachlorobiphenyl | 2.69e-06 | 11 | 59 | 3 | ctd:C010498 | |
| Drug | 4-hydroxyproline | 3.85e-06 | 91 | 59 | 5 | CID000000825 | |
| Drug | 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 4.04e-06 | 163 | 59 | 6 | ctd:D015647 | |
| Drug | escina | 5.11e-06 | 44 | 59 | 4 | CID006433489 | |
| Drug | Madecassol | 6.12e-06 | 46 | 59 | 4 | CID000108062 | |
| Drug | d-indobufen | 8.57e-06 | 50 | 59 | 4 | CID000044562 | |
| Drug | hydroxylysine | 9.34e-06 | 109 | 59 | 5 | CID000001029 | |
| Drug | ridogrel | 1.00e-05 | 52 | 59 | 4 | CID005362391 | |
| Drug | desmosine | 1.08e-05 | 53 | 59 | 4 | CID000025435 | |
| Drug | NSC49633 | 1.08e-05 | 53 | 59 | 4 | CID000023340 | |
| Drug | Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | 1.10e-05 | 194 | 59 | 6 | 3758_DN | |
| Drug | C13932 | 1.54e-05 | 206 | 59 | 6 | CID000168297 | |
| Drug | 2,2',3,5',6-pentachlorobiphenyl | 1.83e-05 | 20 | 59 | 3 | ctd:C032904 | |
| Drug | 2-hydroxycarbazole | 1.98e-05 | 3 | 59 | 2 | CID000093551 | |
| Drug | cis-diammineplatinum(II | 1.98e-05 | 3 | 59 | 2 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 1.98e-05 | 3 | 59 | 2 | CID002750949 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 1.98e-05 | 3 | 59 | 2 | CID005748312 | |
| Drug | 8N3-cADPR | 1.98e-05 | 3 | 59 | 2 | CID000127713 | |
| Drug | aminodantrolene | 1.98e-05 | 3 | 59 | 2 | CID009570289 | |
| Drug | AC1LAKND | 2.03e-05 | 62 | 59 | 4 | CID000470146 | |
| Drug | pirfenidone | 2.93e-05 | 138 | 59 | 5 | CID000040632 | |
| Drug | DL-penicillamine | 3.03e-05 | 139 | 59 | 5 | CID000004727 | |
| Drug | fulvestrant | 3.37e-05 | 484 | 59 | 8 | ctd:C070081 | |
| Drug | malotilate | 3.47e-05 | 71 | 59 | 4 | CID000004006 | |
| Drug | L-3,4-dehydroproline | 3.87e-05 | 73 | 59 | 4 | CID000094284 | |
| Drug | PCB74 | 3.95e-05 | 4 | 59 | 2 | CID000036218 | |
| Drug | 148504-47-6 | 3.95e-05 | 4 | 59 | 2 | CID006444275 | |
| Drug | Azetidinecarboxylic Acid | 3.95e-05 | 4 | 59 | 2 | ctd:D001383 | |
| Drug | SC 38249 | 3.95e-05 | 4 | 59 | 2 | CID000134834 | |
| Drug | AC1L1U7A | 3.95e-05 | 4 | 59 | 2 | CID000035682 | |
| Drug | AC1NMZ1B | 4.31e-05 | 75 | 59 | 4 | CID005034185 | |
| Drug | strontium ranelate | 4.78e-05 | 77 | 59 | 4 | CID006918182 | |
| Drug | isocitrate | 5.26e-05 | 156 | 59 | 5 | CID000001198 | |
| Drug | hyaluronan | 6.05e-05 | 263 | 59 | 6 | CID000024759 | |
| Drug | 2,4-xylidinothiazoline | 6.38e-05 | 30 | 59 | 3 | CID000099296 | |
| Drug | 2-phenylacetylenesulfonamide | 6.57e-05 | 5 | 59 | 2 | ctd:C545747 | |
| Drug | chlorocresol | 6.57e-05 | 5 | 59 | 2 | ctd:C006984 | |
| Drug | A 68930 | 6.57e-05 | 5 | 59 | 2 | ctd:C065380 | |
| Drug | halofuginone lactate | 7.04e-05 | 85 | 59 | 4 | CID000062891 | |
| Drug | CP 31398 | 7.77e-05 | 32 | 59 | 3 | ctd:C402665 | |
| Drug | Butylated Hydroxytoluene | 9.82e-05 | 178 | 59 | 5 | ctd:D002084 | |
| Drug | polaprezinc | 9.84e-05 | 6 | 59 | 2 | ctd:C061957 | |
| Drug | geranylgeranylacetone | 9.84e-05 | 6 | 59 | 2 | ctd:C031049 | |
| Drug | MBED | 9.84e-05 | 6 | 59 | 2 | CID000129958 | |
| Drug | chloro-m-cresol | 9.84e-05 | 6 | 59 | 2 | CID000012008 | |
| Drug | AC1O528X | 9.84e-05 | 6 | 59 | 2 | CID006475857 | |
| Drug | NSC114784 | 9.84e-05 | 6 | 59 | 2 | CID000419425 | |
| Drug | AC1L1DD6 | 1.01e-04 | 179 | 59 | 5 | CID000002299 | |
| Drug | Doxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 1.15e-04 | 184 | 59 | 5 | 5671_DN | |
| Drug | Dextroamphetamine | 1.18e-04 | 185 | 59 | 5 | ctd:D003913 | |
| Drug | 4-chloro-m-cresol | 1.21e-04 | 37 | 59 | 3 | CID000001732 | |
| Drug | pyridinoline | 1.27e-04 | 99 | 59 | 4 | CID000105068 | |
| Drug | AC1L98DX | 1.31e-04 | 38 | 59 | 3 | CID000439957 | |
| Drug | foscarnet | 1.33e-04 | 190 | 59 | 5 | CID000003414 | |
| Drug | Azumoleno | 1.37e-04 | 7 | 59 | 2 | CID000056259 | |
| Drug | Br2BAPTA | 1.37e-04 | 7 | 59 | 2 | CID003081001 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 1.37e-04 | 7 | 59 | 2 | CID009547999 | |
| Drug | NAADP | 1.41e-04 | 39 | 59 | 3 | CID000123952 | |
| Drug | phenanthridinone; Up 200; 51.2uM; MCF7; HT_HG-U133A_EA | 1.44e-04 | 193 | 59 | 5 | 1115_UP | |
| Drug | ticlopidine | 1.48e-04 | 103 | 59 | 4 | CID000005472 | |
| Drug | NSC3260 | 1.51e-04 | 195 | 59 | 5 | CID000220461 | |
| Drug | Midodrine hydrochloride [3092-17-9]; Up 200; 13.8uM; PC3; HT_HG-U133A | 1.51e-04 | 195 | 59 | 5 | 2087_UP | |
| Drug | Hydroquinine hydrobromide hydrate [304695-81-6]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 1.51e-04 | 195 | 59 | 5 | 2767_UP | |
| Drug | Piperacetazine [3819-00-9]; Up 200; 9.8uM; PC3; HT_HG-U133A | 1.51e-04 | 195 | 59 | 5 | 5834_UP | |
| Drug | Sulfameter [651-06-9]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 1.54e-04 | 196 | 59 | 5 | 3453_DN | |
| Drug | resorcinol | 1.58e-04 | 197 | 59 | 5 | ctd:C031389 | |
| Drug | Isoniazid [54-85-3]; Up 200; 29.2uM; PC3; HT_HG-U133A | 1.58e-04 | 197 | 59 | 5 | 5840_UP | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; HL60; HT_HG-U133A | 1.62e-04 | 198 | 59 | 5 | 2197_UP | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; PC3; HT_HG-U133A | 1.62e-04 | 198 | 59 | 5 | 3756_DN | |
| Drug | Diflunisal [22494-42-4]; Up 200; 16uM; MCF7; HT_HG-U133A | 1.62e-04 | 198 | 59 | 5 | 1490_UP | |
| Drug | Norcyclobenzaprine [303-50-4]; Up 200; 15.4uM; HL60; HT_HG-U133A | 1.66e-04 | 199 | 59 | 5 | 2469_UP | |
| Drug | Azlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; PC3; HT_HG-U133A | 1.66e-04 | 199 | 59 | 5 | 5788_DN | |
| Drug | triphenyl(phenylethynyl)phosphonium | 1.83e-04 | 8 | 59 | 2 | ctd:C000608764 | |
| Drug | Pcme | 1.83e-04 | 8 | 59 | 2 | CID000169849 | |
| Drug | AC1L1C2F | 1.91e-04 | 110 | 59 | 4 | CID000001711 | |
| Drug | AC1NE2TZ | 2.03e-04 | 44 | 59 | 3 | CID004635680 | |
| Drug | PPACK | 2.12e-04 | 113 | 59 | 4 | CID003036757 | |
| Drug | AC1L1KF5 | 2.12e-04 | 113 | 59 | 4 | CID000005470 | |
| Drug | AC1L9732 | 2.19e-04 | 114 | 59 | 4 | CID000439300 | |
| Drug | neodymium | 2.27e-04 | 115 | 59 | 4 | CID000023934 | |
| Drug | Tranilast sodium | 2.27e-04 | 115 | 59 | 4 | CID000005527 | |
| Drug | Trientine | 2.67e-04 | 120 | 59 | 4 | ctd:D014266 | |
| Drug | funiferine N-oxide | 2.80e-04 | 49 | 59 | 3 | CID000191631 | |
| Drug | PCB 95 | 2.93e-04 | 10 | 59 | 2 | CID000038012 | |
| Drug | LMWH | 2.97e-04 | 663 | 59 | 8 | CID000000772 | |
| Drug | Selara | 3.12e-04 | 125 | 59 | 4 | CID000150310 | |
| Drug | Methylmercury Compounds | 3.20e-04 | 851 | 59 | 9 | ctd:D008767 | |
| Drug | AC1Q6PCP | 3.23e-04 | 230 | 59 | 5 | CID000005267 | |
| Drug | Raloxifene Hydrochloride | 3.37e-04 | 857 | 59 | 9 | ctd:D020849 | |
| Drug | PCB 66 | 3.58e-04 | 11 | 59 | 2 | CID000036185 | |
| Disease | Ullrich congenital muscular dystrophy (implicated_via_orthology) | 3.54e-06 | 2 | 56 | 2 | DOID:0050558 (implicated_via_orthology) | |
| Disease | Oculopharyngeal muscular dystrophy | 3.54e-06 | 2 | 56 | 2 | cv:C0270952 | |
| Disease | ascending aortic diameter | 7.04e-06 | 140 | 56 | 5 | EFO_0021787 | |
| Disease | Inclusion body myopathy with Paget disease of bone and frontotemporal dementia | 1.06e-05 | 3 | 56 | 2 | cv:C1833662 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.06e-05 | 3 | 56 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.06e-05 | 3 | 56 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE AND FRONTOTEMPORAL DEMENTIA | 1.06e-05 | 3 | 56 | 2 | C1833662 | |
| Disease | Prostatic Neoplasms | 2.03e-05 | 616 | 56 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.03e-05 | 616 | 56 | 8 | C0376358 | |
| Disease | Bethlem myopathy (is_implicated_in) | 2.12e-05 | 4 | 56 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy | 2.12e-05 | 4 | 56 | 2 | cv:C4551860 | |
| Disease | Bethlem myopathy | 2.12e-05 | 4 | 56 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 2.12e-05 | 4 | 56 | 2 | C1834674 | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 2.12e-05 | 4 | 56 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy 1 | 2.12e-05 | 4 | 56 | 2 | C0410179 | |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 3.52e-05 | 5 | 56 | 2 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 5.28e-05 | 6 | 56 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | autosomal dominant limb-girdle muscular dystrophy type 3 (implicated_via_orthology) | 5.28e-05 | 6 | 56 | 2 | DOID:0110306 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 1.05e-04 | 48 | 56 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | aortic measurement | 1.15e-04 | 251 | 56 | 5 | EFO_0020865 | |
| Disease | Major depression, single episode | 1.26e-04 | 9 | 56 | 2 | C0024517 | |
| Disease | Amyotrophic Lateral Sclerosis | 1.86e-04 | 58 | 56 | 3 | C0002736 | |
| Disease | Congenital muscular dystrophy | 2.31e-04 | 12 | 56 | 2 | cv:C0699743 | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 2.72e-04 | 13 | 56 | 2 | C3501611 | |
| Disease | Muscular Dystrophy, Facioscapulohumeral | 2.72e-04 | 13 | 56 | 2 | C0238288 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 3.02e-04 | 169 | 56 | 4 | DOID:3908 (is_marker_for) | |
| Disease | silicosis (biomarker_via_orthology) | 3.17e-04 | 14 | 56 | 2 | DOID:10325 (biomarker_via_orthology) | |
| Disease | Myocardial Ischemia | 3.53e-04 | 176 | 56 | 4 | C0151744 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 4.80e-04 | 80 | 56 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | obesity (implicated_via_orthology) | 7.48e-04 | 215 | 56 | 4 | DOID:9970 (implicated_via_orthology) | |
| Disease | Carcinoma, Pancreatic Ductal | 9.51e-04 | 24 | 56 | 2 | C0887833 | |
| Disease | systemic scleroderma (is_implicated_in) | 9.51e-04 | 24 | 56 | 2 | DOID:418 (is_implicated_in) | |
| Disease | complement C4b measurement | 1.03e-03 | 25 | 56 | 2 | EFO_0008092 | |
| Disease | Major Depressive Disorder | 1.18e-03 | 243 | 56 | 4 | C1269683 | |
| Disease | Mental Retardation, X-Linked | 1.39e-03 | 29 | 56 | 2 | C1136249 | |
| Disease | Bilateral Wilms Tumor | 1.39e-03 | 29 | 56 | 2 | C2930471 | |
| Disease | Unipolar Depression | 1.49e-03 | 259 | 56 | 4 | C0041696 | |
| Disease | Mental Retardation, X-Linked 1 | 1.69e-03 | 32 | 56 | 2 | C2931498 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GGGGDGYYPSGGAWP | 66 | O95429 | |
| PYGTDIGPGGGYGAA | 1336 | Q9UMD9 | |
| GVYGQESGGFSGPGE | 276 | Q01844 | |
| YQYGPSSAGNGAGGG | 11 | O43707 | |
| SSGYPGAGGYPAPGG | 51 | P20073 | |
| QGFGVPPGGAGFSGY | 91 | P20073 | |
| GGGEPGEGAYSQPGY | 26 | Q9UPS8 | |
| AVEEGGGPGGQGFSY | 91 | P18075 | |
| YYTNQQHPAGGGGGG | 66 | Q07687 | |
| GGGGGGSPYAHMGSY | 76 | Q07687 | |
| YLAAEGQPGGEQGGG | 46 | Q8HWS3 | |
| SGGGGGLEPYAGPQQ | 186 | O14497 | |
| YPGGDYSGGPQDGGA | 311 | O14497 | |
| YSGGPQDGGAGKGPA | 316 | O14497 | |
| PGGYGDNLGGGQMYS | 381 | P40425 | |
| VFPLYRGQGGQDGGG | 1191 | A9Z1Z3 | |
| ENYLSGGGPGDGGGA | 146 | Q7Z6M2 | |
| PASQQLSGGYGGGYG | 411 | P55795 | |
| YQGAGGPGPGGFGAQ | 611 | P0DMV9 | |
| NNYSGGYGTPDGLGG | 306 | P31942 | |
| GNEGNGPRPYGGGAA | 126 | O15553 | |
| AEEGQLYGPCGGGGG | 441 | P10275 | |
| YGSGGGGAQQLGAGP | 226 | P31260 | |
| PASQQLSGGYGGGYG | 411 | P31943 | |
| NSGGQYGSGLPPGGG | 31 | Q9UBV8 | |
| YGSGLPPGGGYGGPA | 36 | Q9UBV8 | |
| EQLGGGGSGGGGYNN | 91 | Q14671 | |
| YYGGGAQGADFQPPG | 36 | P09016 | |
| AGQVPPGYSTGGGGG | 111 | Q9BRQ0 | |
| QTDPRAGGGGGGDYG | 21 | Q8NI37 | |
| GEGAPGGAGDYGNGL | 36 | Q86U42 | |
| GPAGGVGGGYGESES | 536 | Q96B18 | |
| GPAGVGGAGAVYGSG | 6 | Q9UBT7 | |
| NGTEGFPGFPGYPGN | 516 | P12109 | |
| GEDGYRGYPGDEGGP | 2056 | P12111 | |
| GEKGSQGFGYPGEQG | 876 | Q96P44 | |
| PGGGNGASAGYGGYS | 41 | Q92796 | |
| GYSQPYGMGGVGGLG | 226 | Q8N4S9 | |
| GAAGGGGGGENYDDP | 81 | P14866 | |
| AGGFPVQGGSGYPLG | 301 | O43638 | |
| YQGAGGPGPGGFGAQ | 611 | P0DMV8 | |
| GFAPSGNGNGYGPGG | 441 | P35556 | |
| GNGNGYGPGGTGFIP | 446 | P35556 | |
| LPYGYGPGGVAGAAG | 226 | P15502 | |
| TYGVGAGGFPGFGVG | 396 | P15502 | |
| YTPYPGAGEGWGGNG | 691 | P21817 | |
| EGYSPYPGGGEEWGG | 701 | Q92736 | |
| GNGGPGPYVGQAGTA | 186 | O60716 | |
| GGGHVAYGPQGNGCF | 486 | Q14D33 | |
| PGDAYGDAGYGQGPG | 246 | P08247 | |
| GDAGYGQGPGGYGPQ | 251 | P08247 | |
| GQGPGGYGPQDSYGP | 256 | P08247 | |
| QGGYQPDYGQPAGSG | 271 | P08247 | |
| PDYGQPAGSGGSGYG | 276 | P08247 | |
| PAGSGGSGYGPQGDY | 281 | P08247 | |
| PAGGGGGGYSSYGNS | 106 | P55808 | |
| DVGFGGYGAEGGEPG | 321 | P55318 | |
| GGAGGQAYSPGQPQG | 436 | Q9ULL5 | |
| FPPLGGGGGIGYEAN | 631 | P23246 | |
| GAGGYTQSPGGFGSP | 16 | P15927 | |
| PGPGSNFRGGSDGYG | 221 | P22626 | |
| FGGSRNMGGPYGGGN | 321 | P22626 | |
| NMGGPYGGGNYGPGG | 326 | P22626 | |
| GVPGGNGTGPGIYSY | 106 | Q5BIV9 | |
| YDVSNGGQPGGGGEY | 516 | O43280 | |
| GGQPGGGGEYEVQEG | 521 | O43280 | |
| GGDGGNYGGGPGYSS | 271 | P51991 | |
| GAPGFTTGYAGGPGG | 116 | Q8NF64 | |
| GNFGGRSSGPYGGGG | 331 | P09651 | |
| GGYGGAPGGPAFPGQ | 16 | P30626 | |
| YPGGQGDYAGFPGCG | 546 | Q6PFW1 | |
| GSGGFGASYPGGPNA | 246 | Q9ULJ6 | |
| GMGPAGGFPNAGGHY | 406 | Q9Y493 | |
| RGPGPEGGGGGSYFS | 56 | P17275 |